Louisiana State University

LSU Digital Commons
LSU Doctoral Dissertations

Graduate School

2002

Role of chondrocyte apoptosis in the pathogenesis of equine
osteoarthritis
Dae Young Kim
Louisiana State University and Agricultural and Mechanical College

Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations

Recommended Citation
Kim, Dae Young, "Role of chondrocyte apoptosis in the pathogenesis of equine osteoarthritis" (2002). LSU
Doctoral Dissertations. 1855.
https://digitalcommons.lsu.edu/gradschool_dissertations/1855

This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It
has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU
Digital Commons. For more information, please contactgradetd@lsu.edu.

ROLE OF CHONDROCYTE APOPTOSIS IN THE PATHOGENESIS OF EQUINE
OSTEOARTHRITIS

A Dissertation
Submitted to the Graduate Faculty of the
Louisiana State University and
Agricultural and Mechanical Collage
In partial fulfillment of the
Requirements for the degree of
Doctor of Philosophy
In
The Interdepartmental Programs in Veterinary Medical Sciences
through the Department of Pathobiological Sciences

by
Dae Young Kim
D.V.M., Seoul National University, Korea, 1991
M.S., Seoul National University, Korea, 1995
May 2002

ACKNOWLEDGMENTS
I would like to sincerely thank Drs. Cho and Taylor who warmly welcomed me to the
departmental family five years ago. They have provided me both with the opportunity to study
veterinary pathology and the generous, continuous, advice and encouragement needed to
complete my training. This project would not have been possible without their efforts and the
financial support of the department. I am also thankful to the other members of my graduate
committee: Dr. Paulsen who kindly became my committee member when I desperately
needed him, Dr. Moore who I admire for his professionalism and his enthusiasm toward
research, and Dr. Manhein, “The Bone Lady”, who showed me the interesting world of
forensic anthropology. I also appreciate Drs. Goad and Oliver who gave me the opportunity
to study this project. Thanks to the many veterinary pathologists who have generously shared
their expertise in my residency training: Drs. Bauer, Evans, Gaunt, Hodgin, Johnson, and
Snider. Special thanks to Dr. Barker and Marian Waguespack in the department of
Comparative Biomedical Sciences. They freely opened the door for me when I needed
technical support for the HPLC equipment. I am thankful to Dr. Rhett Stout and Michael L.
Kearney who helped me to solve statistical problems.
I am grateful to department staff. I won’t forget the kindness and countless support
from Cheryl, Del, Hal, Julie, Kendra, Pam, Petesie, and Thaya. I am especially indebted to
Mae Lopez. She has been my colleague, counselor, guardian, and friend. She will always
have a special place in my heart.
I thank my fellow pathology residents, past and present, for sharing my graduate
experience and sweet memories at LSU: Tom Vicek, Ureal Blas, Thomas Lemarchand, Al
Camus, Kristina Porthouse, Chris Roberts, and Wael Hananeh.
Most importantly, I thank my grandmother, parents, and parents-in laws who have
provided me the encouragement through this endeavor, and my wife, Yumi, and my son,
Mingu, for their patience, understanding, and love during this work.

ii

TABLE OF CONTENTS
ACKNOWLEDGMENTS……………………………………………………………………ii
LIST OF TABLES……………………………………………………………………………v
LIST OF FIGURES…………………………………………………………………….……vi
ABSTRACT………………………………………………………………………………..viii
INTRODUCTION………………………………………………………………………….. 1
CHAPTER I: LITERATURE REVIEW…………………………………………… ……… 5
Articular Cartilage…………………………………………………………………... 5
Normal Articular Cartilage…………………………….……………………..5
Articular Cartilage in Osteoarthritis…………………..…………………….. 7
Osteoarthritis in Horses…………………………………………………….. 9
Apoptosis…………………………………………………………………………... 10
Apoptosis and Necrosis……………………………………………………..10
Mechanisms of Apoptosis….…………………………………………….. 11
1. Apoptotic Death Signals……………………………………… 11
2. Activation of Caspases…………………………………………. 12
3. Bcl-2 Family Proteins………………………………………... 14
4. Inhibitors of Apoptosis Proteins……………………………... 15
5. Protein Degradation and DNA Fragmentation……………….. 15
6. Phagocytic Recognition……………………………………… 16
CHAPTER II: CHONDROCYTE APOPTOSIS IN EQUINE OSTEOARTHRITIS….….. 18
Introduction……………………………………………………………….………... 18
Materials and Methods………………………………………………….……….. 19
Equine Articular Cartilage……………………………………….……….. 19
Histopathologic Evaluation…………………………………………….…...19
In situ Detection of Chondrocyte Apoptosis ……………………..…….… 19
Immunohistochemistry for Nitrotyrosine………………………………….. 20
Data Analysis………………………………………………………………. 21
Results……………………………………………………………………………... 21
Histopathologic Evaluation………………………………………………… 21
Chondrocyte Apoptosis…………………………………………………….. 21
Correlation between Histopathologic Grade and Chondrocyte Apoptosis… 25
Detection of Nitrotyrosine…………………………………………………. 25
Discussion…………………………………………………………………………. 27

iii

CHAPTER III: CYCLIC HYDROSTATIC PRESSUE INDUCES EQUINE
CHONDROCYTE APOPTOSIS………………………………………………….. 29
Introduction………………………………………………………………………… 29
Materials and Methods…………………………………………………………….. 30
Equine Chondrocyte Isolation………………………………………………30
Construction of Alginate Beads……………………………..…………….. 30
Application of Hydrostatic Pressure……………………………………….. 31
Immunocytochemistry for Chondrocyte Apoptosis……………………… 31
Quantification of Chondrocyte Apoptosis and Statistical Analysis………. 33
Results…………………………………………………………………………….. 33
Discussion………………………………………………………………………… 38
CHAPTER IV: INCREASED NITRIC OXIDE PRODUCTION AND BCL-2 AND
CASPASE-3 EXPRESSION BY EQUINE ARTICULAR CHONDROCYTES
UNDER CYCLIC HYDROSTATIC PRESSURE: LINKAGE TO
CHONDROCYTE APOPTOSIS………………………………………………….. 42
Introduction………………………………………………………………………… 42
Materials and Methods…………………………………………………………….. 43
Equine Chondrocyte Isolation………………………………………………43
Application of Hydrostatic Pressure……………………………………….. 44
Nitrite Assay……………………………………………………………….. 45
Immunocytochemistry for Bcl-2 and Caspase-3……………………………45
Data Analysis………………………………………………………………. 46
Results…………………………………………………………………………….. 46
Nitrite Assay……………………………………………………………….. 46
Immunocytochemistry for Bcl-2…………………………………………… 46
Immunocytochemistry for Caspase-3……………………………………… 50
Discussion………………………………………………………………………….. 52
SUMMARY……………………………………………………………………………….. 56
BIBLIOGRAPHY………………………………………………………………………….. 58
VITA……………………………………………………………………………………….. 71

iv

LIST OF TABLES
2.1. Histopathologic criteria for osteoarthritis…………………………………….…….…. 20
2.2. Percentage of apoptotic cells in equine articular cartilage (mean ± SD)……………… 23
3.1. Apoptosis of pressure-loaded and control chondrocytes isolated
from superficial and deep layers of equine articular cartilage (mean ± SD)…………..34
3.2. Relative increase of chondrocyte apoptosis in the pressure-loaded
experimental groups compared with the corresponding control groups
(mean ± SD)………………………………………………………………………….…35
4.1. Nitrite concentration from pressure-loaded and control chondrocytes
from equine articular cartilages (µM/103 cells)………………………………………..47

v

LIST OF FIGURES
2.1. Equine normal articular cartilage. No microscopic abnormalities are noted…………..22
2.2. Articular cartilage from an osteoarthritic horse. Note the severe fibrillation of
the articular surface and chondrocyte clustering (cloning)……………………………..22
2.3. TUNEL staining for detecting DNA fragmentation in equine normal articular
cartilage. No cells with positive immunoreactivity are noted…………………………24
2.4. TUNEL staining for detecting DNA fragmentation in equine osteoarthritic
articular cartilage. Note positive immunoreactivity in the clusters of chondrocytes
in the areas of fibrillation……………………………………………………………….24
2.5. Correlation between histopathologic grade and chondrocyte
apoptosis (p<0.001)……………………………………………………..……………...25
2.6. Immunohistochemistry for nitrotyrosine in equine normal articular cartilage.
Positive immunoreactivity is limited to the chondrocytic cytoplasm and
the pericellular matrix in the superficial and upper middle layers……………………..26
2.7. Immunohistochemistry for nitrotyrosine in equine osteoarthritic articular cartilage.
Note intensely positive immunoreactivity of the chondrocytes as well as cartilage
matrix in a diffuse pattern in the areas of fibrillation…………………………………..26
3.1. Hydrostatic pressure loading system…………………………………………………...32
3.2. TUNEL staining for detection of apoptotic chondrocytes. The control
chondrocytes that were isolated from superficial layers of equine articular cartilage
and were not subjected to pressure. No chondrocytes are positively stained………….36
3.3. TUNEL staining for detection of apoptotic chondrocytes. The chondrocytes
were isolated from superficial layers of equine articular cartilage and pressured
with a cyclic hydrostatic pressure of 6.8 MPa for 12 hours. Note increased
apoptotic chondrocytes over the control………………………………………………..36
3.4. TUNEL staining for detection of apoptotic chondrocytes. The control chondrocytes
that were isolated from deep layers of equine articular cartilage and were not
subject to pressure. A few chondrocytes shows immunopositivity…………………….37
3.5. TUNEL staining for detection of apoptotic chondrocytes. The chondrocytes were
isolated from deep layers of equine articular cartilage and pressured with a cyclic
hydrostatic pressure of 6.8 MPa for 12 hours. Note increased apoptotic
chondrocytes over the control………………………………………………………….37

vi

4.1. Immunocytochemistry for Bcl-2 in the control chondrocytes isolated from
superficial layers of equine articular cartilages. The cytoplasm is partially
stained with fine chromogen particles………………………………………………….48
4.2. Immunocytochemistry for Bcl-2 in the hydrostatic pressure-loaded chondrocytes
isolated from superficial layers of equine articular cartilages. Note the stronger
immunopositivity compared with the control…………………………………………48
4.3. Immunocytochemistry for Bcl-2 in the control chondrocytes isolated from
deep layers of equine articular cartilages. The cytoplasm is partially stained
with fine chromogen granules while immunopositivity appears stronger than
the control chondrocytes from superficial layers………………………………………49
4.4. Immunocytochemistry for Bcl-2 in the hydrostatic pressure-loaded chondrocytes
isolated from deep layers of equine articular cartilages. The cytoplasm is
diffusely and strongly stained………………………………………………………….49
4.5. Immunocytochemistry for caspase-3 in the control chondrocytes isolated from
superficial layers of equine articular cartilages. Note diffusely stained
cytoplasm and occasional densely stained nuclei……………………………………...50
4.6. Immunocytochemistry for caspase-3 in the hydrostatic pressure-loaded
chondrocytes isolated from superficial layers of equine articular cartilages.
The densely stained nuclei are more frequent and the cytoplasm shows increased
immunopositivity over the control……………………………………………………..51
4.7. Immunocytochemistry for caspase-3 in the control chondrocytes isolated from
deep layers of equine articular cartilages. Note diffusely stained cytoplasm and
occasional densely stained nuclei………………………………………………………51
4.8. Immunocytochemistry for caspase-3 in the hydrostatic pressure-loaded
chondrocytes isolated from deep layers of equine articular cartilages. Note
frequently stained nuclei as well as much stronger immunopositivity
in the cytoplasm compared with the control…………..……………………………….52

vii

ABSTRACT
Osteoarthritis (OA), a non-inflammatory, degenerative disease of articular cartilages, is a
common cause of poor performance and early retirement in equine athletes. Pathologically,
OA is characterized by matrix degradation and decreased chondrocyte numbers. A
mechanical stress is believed to be the major etiologic factor of OA development. Recent
studies have indicated that apoptosis is responsible for hypocellularity in OA cartilage and
that chondrocyte death by apoptosis could directly contribute to matrix degradation.
Increased nitric oxide (NO), a free radical, has been implicated as a cause of chondrocyte
apoptosis. No studies, however, have been performed on chondrocyte apoptosis in equine
OA. We investigated chondrocyte apoptosis in equine OA cartilage and its relationship to
matrix degradation and NO production. Furthermore, we studied whether mechanical stress
could induce chondrocyte apoptosis and how NO production and Bcl-2 and caspase-3 proteins
contribute to chondrocyte apoptosis by using a novel pressure-loading system. Five OA and
three normal equine articular cartilage samples were graded histopathologically and stained
with polyclonal nitrotyrosine antibody. Chondrocyte apoptosis was determined by TUNEL
assay. For pressure-loading experiment, equine chondrocytes were isolated separately from
superficial and deep layers of articular cartilages, embedded in alginate constructs, and
intermittently pressurized at 1,000 ± 100 psi (approximately 6.8 ± 0.6 MPa) for 12 hours.
TUNEL assay, immunohistochemistry with polyclonal antisera to Bcl-2 and caspase-3, and
colorimetric nitrite assay were applied to the chondrocytes that adhered on glass slides by
cytospin. Chondrocyte apoptosis occurred much more frequently in equine OA cartilage than
in normal cartilage, and was closely correlated with matrix degradation and NO production.
The cyclic hydrostatic pressure-treated chondrocytes had a higher percentage of apoptosis
than the controls. The pressure-loaded chondrocytes also produced increased NO and
expressed elevated Bcl-2 and caspase-3, as compared with the control groups. The present
study suggests that pressure-induced NO levels play a critical role in the equine chondrocyte
apoptosis process through Bcl-2 and caspase-3 pathways and mechanical stress may
contribute to equine OA pathogenesis via chondrocyte apoptosis induced by endogenous NO.
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INTRODUCTION
Joint pain and loss of mobility are among the leading causes of impairment in middleaged and old people. One of the most important social changes that has occurred in recent
decades is the increased longevity of the population. Today, almost 80% of the population
can expect to live for over 70 years and in the United States, by the year 2050, there will be
16 million people in the 85 and older group (Kraus 1997). Autopsy studies demonstrate that
60 to 70 % of people in their 60s and 70s have evidence of osteoarthritis in their knees
(Felson 1988, Copper 1994). Osteoarthritis (OA) is the most common form of joint disease
and is generally age-related. According to the review by Kraus (1997), arthritis affects
approximately 15% of the total U.S. population, approximately 40 million adults, and, of
these, 16 million (43%) are affected by OA. By the year 2020, owing to the aging of the
population, the prevalence of arthritis is estimated to reach 18.2%, involving more than 59
million people. In 1996, people who had musculoskeletal disorders spent an average of
$3,578 per person for their medical care in the U.S., which was a total of $193 billion in the
nation, the equivalent of 2.5% of the Gross Domestic Product in that year (Yelin et al. 2001).
With increasing longevity of the population, it becomes more important to find ways to
decrease the clinical and financial impact of OA.
OA is also a common cause of lameness and poor performance in horses. Lameness,
in general, has been estimated to account for 68% of the number of training days lost per year
in a population of young Thoroughbred racehorses (Rossdale et al. 1985). One study shows
that OA was responsible for 54% of lame horses (Todhunter and Lust 1992).
OA is pathologically characterized by degradation of cartilage matrix and
chondrocytic death. The pathogenesis of OA is still not fully understood but believed to be
multifactorial including genetic, environmental, metabolic, and biomechanical factors
(Buckwalter and Mankin 1998). Recent studies using electron microscopy, flow cytometry,
and the DNA fragmentation assay (TUNEL) have shown that apoptosis is the major pathway
of the chondrocytic death in the articular cartilage of OA (Blanco et al. 1998, Hashimoto et al.
1998a, Hashimoto et al. 1998b, Hashimoto et al. 1998c, Lotz et al. 1999).
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One of the pivotal questions in OA pathogenesis is whether chondrocytic apoptosis is
the result of or the cause of matrix damage. Hashimoto et al. (1998a) reported that high
numbers of apoptotic chondrocytes were noted in some macroscopically normal human
articular cartilage samples in the control group and suggested that chondrocyte apoptosis may
precede the manifestations of OA. In human OA, there are other indirect evidences
suggesting that chondrocyte apoptosis may contribute to the onset of OA. Human OA is a
mainly age-related disease. One of the remarkable changes of cartilage in the human aging
population is a diffuse and profound loss of chondrocytic cellularity (up to 50% decrease)
with an increase in the number of empty lacunae, matrix calcification, and fibrillation in the
superficial layer (Stockwell 1971, Buckwalter and Mankin 1998). An electron microscopic
study revealed that the empty lacunae were membrane-bound apoptotic bodies containing cell
remnants (Blanco et al. 1998). In addition, those chondrocyte-derived apoptotic bodies
contain abundant pyrophosphohydrolase that precipitate calcium, resulting in calcification of
the articular cartilage (Hashimoto et al. 1998b). These findings further suggest that
chondrocytic apoptosis may be a predisposition to the human OA. Furthermore, those areas
in which apoptotic chondrocytes exist are geometrically correlated with matrix degradation
(Hashimoto et al. 1998a).
Not only is primary (idiopathic, age-related, or genetic) OA associated with
chondrocytic apoptosis, but is also associated with the trauma (joint instability) -induced
secondary OA. In human OA, although primary OA most frequently occurs, there are some
speculations that primary OA may also result from joint injury (Kraus 1997, Buckwalter and
Mankin, 1998). In experimental OA in rabbit knee joints, induced by anterior cruciate
ligament transection, it was revealed that a close correlation existed between extracellular
matrix degradation and levels of chondrocytic apoptosis (Hashimoto et al. 1998c).
In horses, traumatic injury has been suggested to be a common cause of OA. This
may be a single event trauma, leading to what may be a clearly definable injury to one or
more joint structures, or more insidious repetitive traumatic insults. Development of equine
OA is often associated with stresses of racing and training (Cantley et al. 1999). No studies,
however, have been performed on chondrocyte apoptosis in equine OA.
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Articular cartilage is a load-bearing tissue and mechanical stress is believed to be a
major factor of OA, which has been proven by a number of studies using in vivo and in vitro
experimental systems (Burton-Wurster et al. 1993, Lee et al. 1998, Steinmeyer et al. 1999a,
Steinmeyer and Ackermann 1999b). In an in vitro study, Burton-Wurster et al. (1993)
reported that intensely stained necrotic cells were noted in the superficial layers of canine
cartilage explants that were subjected to compressive loads. Recently, in vitro studies have
shown that a repetitive high impact mechanical loading on bovine articular cartilage explants
induces chondrocyte apoptosis, and the number of apoptotic cells was correlated with the
frequency, strength, and duration of applied mechanical pressure (Loening et al. 2000, Chen
et al. 2001, Clements et al. 2001).
Articular cartilage, however, is not a homogenously uniform tissue, but rather
demonstrates a variety of anatomical and biochemical differences, depending on the locations
of the samples taken (Arokoski et al. 1998, Brama et al. 1999, Brama et al. 2000). Because of
the diversity existing between the articular cartilage samples (explants), standardization of the
experimental condition can be problematic. To resolve this problem, an in vitro experimental
system using chondrocytes is greatly needed. An in vitro experimental design to study
hydrostatic pressure-induced chondrocyte apoptosis using cultured chondrocytes has not been
established mainly due to technical difficulties of how to pressurize chondrocytes in vitro
while retaining intact chondrocyte morphological characteristics.
Nitric oxide (NO) is a free radical, acting as a pathophysiological mediator (Liaudet et
al. 2000). Endogenously produced NO is relevant to chondrocyte apoptosis and destruction
of extracellular matrix in vivo (Blanco et al. 1998; Hashimoto et al. 1998a; Hashimoto et al.
1998c; Pelletier et al. 1998; Hashimoto et al. 1999). NO production, in the form of nitrites,
increases in mechanically compressed articular cartilage explants (Loening et al. 2000), but
detailed mechanisms of how NO is integrated in the apoptosis cascade is still not fully
understood.
Bcl-2 is an anti-apoptotic protein that is located in the outer membrane of
mitochondria and prevents mitochondrial permeabilization and release of cytochrome c,
which eventually activates a series of execution caspases to result in cell demise by apoptosis
(Yang et al. 1997). Expression of Bcl-2 is elevated in OA articular cartilage (Kim et al. 2000;
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Pelletier et al. 2000). Increased expression of caspase-3 also occurs in OA articular cartilage
and is correlated with the severity of OA (Matsuo et al. 2001). Caspase-3 is up-regulated in
chondrocyte apoptosis induced by exogenous NO (Notoya et al. 2000; Kim et al. 2002).
Hypotheses of this study were 1) mechanical stress directly induces chondrocyte
apoptosis resulting in matrix degeneration and 2) NO plays an important role in mechanical
stress-induced chondrocyte apoptosis.
The specific goals of this study were:
1) To investigate whether chondrocyte apoptosis occurs in the articular cartilage of
horses with OA and to examine the relationships of chondrocyte apoptosis with
cartilage degeneration and levels of NO production in vivo.
2) To establish a hydrostatic pressure-loading system and to test a hypothesis that
mechanical force directly causes chondrocytic apoptosis in vitro.
3) To examine the relationships between hydrostatic pressure-induced chondrocyte
apoptosis and levels of apoptosis-related biological mediators such as NO, Bcl-2
and caspase-3 in vitro.
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CAPTER I: LITERATURE REVIEW
Articular Cartilage
Normal Articular Cartilage
Articular cartilage is a thin layer of deformable, load-bearing material that lines the
bony ends of diarthrodial joints. The primary functions of articular cartilage are to support
and distribute forces generated during joint loading, stabilize and guide joint motions, and
contribute to joint lubrication (Mow et al. 1992). Articular cartilage is composed of
chondrocytes (1 to 2 % of the dry tissue volume) embedded in extracellular matrix (98 to 99%
of the dry tissue volume). The cartilage extracellular matrix is produced and maintained by
the chondrocytes, which are the only cells in the cartilage. There are three anatomical layers
of articular cartilage through the tissue depth: (1) Superficial (surface) layer characterized by
flattened disc-shaped chondrocytes; (2) Middle (transitional) layer where the chondrocytes
are rounded and separated from each other with abundant cartilage matrix; and (3) Deep layer
characterized by rounded chondrocytes arranged in columns (Archer et al. 1994). The main
components of extracellular matrix are collagens and proteoglycans. Type II collagen, which
represents approximately 95% of the total collagen weight (Scher et al. 1996), is the major
component of the matrix, with minor amounts of types VI, IX, X, and XI collagens normally
present (Heinegard and Oldberg 1989, Eyre et al. 1992). The collagen fibrillar network acts
as both a structural framework to provide mechanical support to the tissue, and as a binding
surface for molecules involved in mediating either matrix-matrix or cell-matrix interactions
(Scher et al. 1996). Type IX collagen serves to link type II collagen fibrils and connect type
II collagen to the matrix proteoglycans (Brierley et al. 1991, Aigner et al. 1993).
The large, aggregating proteoglycan in articular cartilage is known as aggrecan.
Aggrecan consists of a core protein with multiple glycosaminoglycan side chains covalently
attached. The core protein has three globular molecular domains, G1, G2, and G3, and
hyaluronic acid binds to the N-terminal of G1 domain (Scher et al. 1996). Proteoglycan
aggregates are formed by the binding of many proteoglycan monomers to a chain of
hyaluronic acid. The proteoglycans affect the cartilage’s mechanical and physical properties,
such as compressive stiffness, sheer stiffness, osmotic pressure, and regulation of hydration
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(Buckwalter et al. 1994). The proteoglycan molecule has been one of the main targets as an
OA marker, because it can represent the degree of cartilage synthesis, repair, and
degeneration (Saxne et al. 1987, Silverman et al. 1990, Ratcliffe et al. 1993).
Articular cartilage is saturated with water. The water phase of cartilage constitutes
from 65 to 85% of the total tissue weight and is important in controlling many physical
properties. The proteoglycans are negatively charged due to the presence of carboxyl and
sulfate groups on the glycosaminoglycans which confer a net negative charge on the cartilage
extracellular matrix. As a result, cartilage is highly hydrophilic, with a tendency to imbibe
fluid, or swell, in order to maintain mechanochemical equilibrium. This property contributes
significantly to the mechanical function of articular cartilage by generating a large swelling
pressure against deformations (Setton et al. 1999).
Biomechanical composition and arrangement of collagens and proteoglycans in the
matrix differ by the anatomical location. Collagen fibers in the superficial layer of articular
cartilage are densely packed and oriented parallel to the articular surface (Clark 1991). Thus,
a relatively low proteoglycan content and a low permeability to fluid flow are characteristics
of the superficial layer (Mansour and Mow 1976, Mow et al. 1984, Setton et al. 1993). In the
middle layer, the collagen fibers are either random or radially oriented (Clark 1991) and the
proteoglycan content is at a maximum value for the tissue (Venn and Maroudas 1977). In the
deep layer, the collagen fibers are larger and form bundles, which are oriented perpendicular
to the subchondral bone (Clark 1991) and the proteoglycan content is low (Venn and
Maroudas 1977).
One of the unique anatomical characteristics of articular cartilage is avascularity
(Gardner 1994). Therefore, articular chondrocytes rely on fluid-mediated nutritional delivery
from the synovial fluid (Mow et al. 1984). Low molecular weight solutes, such as glucose,
are transported by simple diffusion, but a mechanical pumping action of articular cartilage
during joint movement is probably associated with the supply for large molecular weight
solutes, such as serum albumin, by continuous expulsion and imbibition of interstitial fluid.
This idea has been supported by signs of cartilage degeneration when there is no rhythmic
stressing (Salter et al. 1980; Kiviranta et al. 1987).
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Articular Cartilage in Osteoarthritis
OA is a non-inflammatory, degenerative joint disease, which is also referred as
degenerative osteoarthritis, osteoarthrosis, and hypertrophic osteoarthritis. Despite
concentrated research on OA in recent years, the pathogenesis of OA is still not fully
understood. The causes of OA are believed to be multifactorial including genetic,
environmental, metabolic, and biomechanical. OA can be grouped into primary (idiopathic)
OA and secondary OA that has identifiable risk factors and causes (Buckwalter and Mankin
1998). Primary OA is the most common form in the human (prevalently in the elderly) and
the cause is unknown (idiopathic). On the other hand, secondary OA can arise as a result of
joint injury or a physiopathological alteration of cartilage matrix or subchondral bone caused
by hereditary, developmental, metabolic, and neurologic disorders (Buckwalter and Mankin
1998). Risk factors associated with OA include age, obesity (Nevitt and Lane 1999, Sharma
et al. 2000), high bone mineral density (Nevitt et al. 1995), joint hypermobility and instability
(Howell et al. 1992), joint trauma, immobilization, peripheral neuropathy (due to syphilis,
diabetes mellitus, leprosy, etc.), crystal formation in cartilage (Felson 1993), and repetitive
joint overuse (Anderson and Felson 1988, Felson 1988, Felson et al. 1991). Effect of
estrogen on the development of OA remains controversial (Sandmark et al. 1999, Wluka et al.
2001). Smoking, however, is believed to protect against development of severe forms of OA
(Lavernia et al. 1999, Sandmark et al. 1999).
The degeneration or progressive loss of normal structure and function of articular
cartilage is the fundamental tenant of osteoarthritis. Studies on changes of collagens in OA
indicate a very slow turnover of collagen type II in vivo in adult humans, and the small
amounts of the “minor” collagens present in the matrix (Maroudas 1980). A shift in the
collagen composition in OA cartilage matrix occurs with increased concentrations of collagen
types I and III, which are considered as “noncartilage” collagens (Aigner et al. 1993). Type X
collagen is normally present only in sites near cartilage mineralization where chondrocytes
are hypertrophic (Grant et al. 1985). In OA, several investigators have reported an increased
expression of collagen type X both at sites of osteophytes and in clusters of chondrocytes in
fibrillated cartilage matrix (Hoyland et al. 1991). Type VI collagen is normally located in the
pericellular areas surrounding articular chondrocytes. The fact that cartilage with OA is

7

enriched in collagen type VI suggests that synthesis of this collagen is also activated in OA
(Poole 1991).
Major shifts are found in the turnover and structure of aggrecan in both experimental
and human OA. Synthesis of aggrecans increases in advancing OA, while in advanced OA,
incorporation rate of aggrecans to other extracellular matrix molecules decreases (Bulstra et
al. 1989). The structure of the newly synthesized aggrecan molecules in OA cartilage appears
to differ from that of normal cartilage. Molecules synthesized as a response to the early
phases of OA were reported to be of larger hydrodynamic sizes than normal, with longer
chondroitin sulphate chains (Bulstra et al. 1989). Alterations of the sulphation patterns of the
chondroitin sulphate chains as a response to OA are indicative of modified synthesis of
aggrecan molecules (Rizkalla et al. 1992). The functional significance of this modification is
unknown, but it is possible that it could alter the interaction of the glycosaminoglycan chains
with growth factors or with other components of the matrix (Bayliss 1992). A consistent
finding in experimental and human OA cartilage is an increased release of both pre-existing
and newly synthesized aggrecan (Inerot et al. 1991).
It is generally assumed that the destruction of joint cartilage matrix in OA is caused by
the action of proteases, which are released by the chondrocytes themselves, by cells in the
synovial fluid such as leukocytes and macrophages, or by cells in the synovium. Proteolytic
enzymes are classified into four distinct types depending on their catalytic mechanism: serine
proteinases, cystein proteinases, aspartic proteinases and metalloproteinases (Barrett and
Saklatvala 1985). Matrix metalloproteinases (MMP’s), synthesized both by chondrocytes and
by synovial cells (Woessner 1991; Clegg et al. 1997), are involved in the degradation of
cartilage collagens during the development of OA (Lohmander 1994; Freemont et al. 1997).
MMP’s are a group of zinc dependent endopeptidases that are centrally involved in the
normal physiological turnover of the extracellular matrix. The MMP’s can be divided into
three groups: collagenases (MMP 1 and 8), type IV collagenases/gelatinases (MMP 2 and 9),
and stromelysins/proteoglycanases (MMP 3 and 10) (reviewed by Clegg et al. 1997).
When the articular cartilage is damaged, there is an initial increase in the water
content of the cartilage. As the collagen lattice of the matrix is disrupted, more water is
attracted to the negatively charged glycosaminoglycan chains, resulting in swelling of the
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cartilage. Once the surface layer of cartilage is fibrillated, the resistance to shear forces is
lessened and, as OA progresses, the cartilage develops deep clefts and matrix disruption
occurs. The fissures usually form vertically because the collagen fibers are vertically oriented
in the deep cartilage layers (reviewed by Kidd et al. 2001).
Osteoarthritis in Horses
OA is a common cause of lameness and poor performance in horses. Lameness, in
general, has been estimated to account for 68% of the number of training days lost per year in
a population of young Thoroughbred racehorses (Rossdale et al. 1985). Another study shows
that OA was responsible for 54% of lame horses (Todhunter and Lust 1992).
An exact etiology of equine OA or its effective treatment has not been elucidated.
Trauma has been suggested to be a common etiological factor in the occurrence of OA. This
may be a single event trauma or more insidious damage caused by multiple repetitive
traumatic insults. The latter, commonly called “use trauma”, implies that the traumatic
damage is due to the normal, day-to-day activities, which may include athletic training and
competition (Kidd et al. 2001). Recently, OA has been described in a herd of wild ponies
(Cantley et al. 1999) and the authors suggest that equine OA can occur spontaneously and that
development of OA in horses may be accelerated by the stresses of racing and training. The
hypothesis that use trauma is the most common cause of OA is also supported by the
increased incidence of OA in young horses used for athletic activity (Hoffman et al. 1984). A
certain amount of joint loading is required in healthy joints to lubricate the joint and stimulate
production of matrical proteins but excessive loading is unfavorable, suggesting that there is
an injurious threshold of joint loading (Evans and Brown 1993).
Equine OA is most frequently manifested clinically as a slowly progressive lameness,
which can often be bilateral. There may be joint pain, decreased range of motion, variable
joint effusion, and inflammation, which is not systemic but commonly localized to the
synovial membrane and joint capsule (Kidd et al. 2001). As a response to cytokines, such as
IL-1, and other inflammatory mediators from chondrocytes in OA cartilage, the joint capsule
and synovium increase their vascularity and begin to thicken. In addition, synovial cells in
the swollen synovium release pro-inflammatory cytokines and mediators into the synovial
fluid to hasten the cartilage matrix degradation. Commonly affected joints in OA horses
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include metacarpophalangeal joints (most common), carpal joints, distal intertarsal and
tarsometatarsal joints, and proximal interphalangeal joints.
Apoptosis
The term, “apoptosis”, was first used by Kerr et al. in 1972 to describe a specific form
of cell death. Apoptosis is an ancient Greek word meaning the “falling off” of leaves from
trees or petals from flowers. It refers to the particular morphology of physiological cell death,
which has specific features of membrane blebs and apoptotic bodies separating from the
apoptotic cells. The term apoptosis is also frequently referred to as programmed cell death
implying that the cell death results from a precisely regulated activation of a series of
preexisting factors in a death program that is encoded in the genome.
Apoptosis is not a newly described phenomenon. In 1858, Virchow described the
progressive changes in the appearance of body tissues shortly after death. He described
necrosis being where “the mortified cell is left in its external form” and “necrobiosis or
shrinkage necrosis being where the cell vanishes and can no longer be seen in its previous
form”. The necrobiosis, which he described, is what we recently call apoptosis (Afford and
Randhawa 2000).
Apoptosis and Necrosis
Apoptosis is characterized morphologically by cell shrinkage, nuclear condensation,
membrane blebbing, formation of apoptotic bodies, and phagocytosis by neighboring cells or
phagocytic cells. Apoptosis occurs in embryogenesis and development when forming a body
cavity by eliminating cells. In mature animals, apoptosis maintains the constancy of tissue
mass as the counterpart of cell division (Saikumar et al. 1999). The tadpole’s tail disappears
by apoptosis during metamorphosis, which is triggered by a surge of thyroid hormone in the
blood stream (Kashiwagi et al. 1999). During veterbrate development, more neurons are
produced than are needed, and apoptosis eliminates 20% to 80% of them. This is regulated by
the limited amounts of nerve growth factor produced by other cells (Clarke et al. 1998).
Removal of cells injured by genetic defects, aging, disease, or exposure to noxious
agents is accomplished by apoptosis (Saikumar et al. 1999). During ischemic conditions,
such as myocardial infarction and stroke, cells die not only by necrosis but also apoptosis
(Geng 1997). In the acquired immunodeficiency syndrome (AIDS), the human
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immunodeficiency virus (HIV) causes the death of T-helper cells that are necessary to
activate and prevent apoptotic death of cytotoxic T cells (Kalams and Walker 1998). Other
pathological conditions that are related to apoptosis include autoimmune diseases, such as
systemic lupus erythematosus and Hashimoto’s thyroiditis, Parkinson’s and Alzheimer’s
diseases, reticular degeneration, and B-cell lymphoma (Saikumar et al. 1999).
Apoptosis can be differentiated from the other form of cell death, termed necrosis.
Necrosis occurs in response to injury by physical stimuli, toxins, or ischemia. Swelling of
cells, disruption of membranes, and lysis of nuclear chromatin are prominent features of
necrosis.
Confusingly, a mixed form of cell death simultaneously having apoptotic and necrotic
morphology may be seen. This is the superimposition of “secondary necrosis” upon apoptosis
caused by overlapping necrotic and apoptotic processes (Papassotiropoulos et al. 1996).
The fate of cell death whether apoptotic, necrotic, or secondary necrosis is determined
by the intensity and duration of injurious damage as well as the level of cellular energy
supply. Unlike necrosis, apoptosis requires cellular ATP to execute the process (Saikumar et
al. 1998; Leist et al. 1999). Thus, cells injured by stressful stimuli may enter apoptotic
process, but undergo necrosis secondarily when energy levels within cells decline.
Mechanisms of Apoptosis
Apoptosis was first characterized during genetic studies on the nematode worm,
Caenorhabditis elegans. C. elegans development involves the activation of selective death
genes that kill exactly 131 cells and leave 959 cells intact in the worm (Ellis and Horvitz
1986). Apoptosis consists of three successive stages: 1) commitment to death triggered by
extracellular or intracellular signals; 2) execution of cell killing by activation of intracellular
proteinases; and 3) removal of dead cells through engulfment of cell remnants by other cells,
followed by digestion of the remnants within lysosomes of phagocytic cells (Saikumar et al.
1999).
1. Apoptotic Death Signals
Cellular decisions to initiate apoptotic programs are governed by either removal of
survival signals or extracellular or intracellular death signals. Removal of adherent epithelial
cells from extracellular matrix is a good example of removal of survival signals. Integrin
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receptor-mediated signal transduction is required for the survival of anchorage-dependent
cells (Ruoslahti and Reed 1994). Elimination of soluble growth factors, which are also
important sources for survival signals, can trigger apoptosis (Feng et al. 1998).
There are some extracellular stimuli that can advance to apoptotic death. This process
can be triggered by agents that can penetrate the cell directly and modulate the apoptotic
cascade in the absence of specific cell surface receptors. Examples of such stimuli include
heat shock/stress factors, free radicals, UV radiation, drugs, synthetic peptides, toxins, and
lymphocytic granzymes (Afford and Randhawa 2000). Other mechanisms are dependent on
expression of appropriate cell surface receptors.
The best-characterized receptor associated-apoptotic signaling pathway involves
binding of proteins, such as tumor necrosis factor-alpha (TNF-α) and Fas ligand (FasL), to
their corresponding surface receptors TNFR1 and Fas (APO-1 or CD95) (Magnusson and
Vaux 1999). Fas and FasL are implicated in peripheral deletion of autoreactive T cells,
activation-induced T cell death, and one of the two cytolytic pathways mediated by CD8+
cytolytic cells (Nagata 1997). Although FasL was initially thought to be lymphoid specific,
studies have shown that FasL is constitutively expressed in a variety of nonlymphid tissues
including heart, pancreas, and articular cartilage (French and Tschopp 1996; Hashimoto et al.
1997). Fas is a glycosylated 45 kD transmembrane receptor that belongs to the TNF receptor
superfamily, which is composed of at least 19 members (Smith et al. 1994).
Death receptors such as Fas and TNFR1 contain cytoplasmic domains (death domains)
of approximately 80 amino acids that are essential for generating death signals (Hofmann and
Tschopp 1995). After binding to their corresponding ligands, death receptors form
homotrimeric complexes and recruit intracellular adapter proteins to the cell membrane. In
the case of TNFR1, the adaptor protein is TNFR-associated death domain protein (TRADD),
whereas Fas interacts with Fas-associated death domain protein (FADD). Binding of
TRADD or FADD to the death domains causes the activation of procaspase-8, an initiator
caspase, which sequentially activates execution caspases (Saikumar et al. 1999).
2. Activation of Caspases
Caspases (cysteine aspartyl-specific proteases) are intracellular cysteine proteinases
that cleave their substrates at aspartic acid residues (Reed 2000). These proteinases are
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present as inactive zymogens in essentially all animal cells, but can be triggered to active
stages. In humans and mice, approximately 14 caspases have been identified and can be
subgrouped into initiator caspases and execution caspases according to their functional
specificities (Huppertz et al. 1999; Reed 2000). One of the functional differences between
initiator caspases and execution caspases is that once the execution caspases are activated, the
process of cell death cannot be reversed (Saikumar et al. 1999). Although most caspases are
directly involved in cell apoptosis, a few are not, at least in mammals and higher eukaryotes.
A group of caspases, including caspases-1, -4, and –5 in humans, is involved in processing of
pro-inflammatory cytokines (Reed 2000).
Among the initiator caspases, caspase-8 and caspase-9 are the most studied. After the
binding of peptides such as TNF-α or FasL, their receptors oligomerize and recruit adaptor
proteins (FADD, TRADD) to form death-inducing signal complexes (DISC), causing the
activation of the caspase-8. Caspase-8 cleaves Bid (a pro-apoptotic Bcl-2 protein), yielding a
15kD protein, which migrates to mitochondria and releases cytochrome c. Released
cytochrome c activates caspase-9 by binding to the caspase-activating protein Apaf-1
(apoptotic protease activating factor-1). Consequential activation of caspase-3, a potent
execution caspase, occurs by activated caspase-9 (Saikumar et al. 1999).
Initiator caspases are also responsible for early proteolytic events such as the cleavage
of cytoskeletal and related proteins including vimentin, actin, and fodrin (a membrane
associated cytoskeletal protein) (Huppertz et al. 1999). These early apoptotic events are
believed to be responsible for the characteristic blebbing of the cell surface (McCarthy et al.
1997).
Important mammalian execution caspases are caspases-3, -6, and –7. Their activation
leads to the degradation of a variety of proteins and to the activation of enzymes, e.g.
nuclease. Therefore, the activation of these execution caspases is the hallmark of apoptosis
(Huppertz et al. 1999). Selective inhibitors of caspase-3 inhibit apoptosis (Lee et al. 2000).
Caspase-3 has been found to be activated in virtually every model of apoptosis (Porter and
Janicke 1999). Natural substrates of caspase-3 include many proteins involved in cell
maintenance and repair (Nicholson and Thornberry 1997). For example, oligonucleosome
fragmentation (DNA laddering) is a characteristic feature of apoptosis and is mediated by
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caspase-activated deoxyribonuclease (CAD), whose activation is effected by the caspase-3mediated cleavage of the CAD inhibitor, ICAD (Enari et al. 1998).
Caspases-6 and –7 are other members of execution caspases (Lincz 1998). In some
systems, caspase-6 was found to be activated prior to caspases-3 (Grossmann et al. 1998); in
others caspase-8 activates caspase-3, which in turn activates caspase-7, leading finally to the
activation of caspase-6 (Cohen 1997).
3. Bcl-2 Family Proteins
The mitochondria-dependent pathway for apoptosis is governed by Bcl-2 family
proteins. There are both pro-apoptotic and anti-apoptotic Bcl-2 family proteins and many of
these proteins physically bind each other, forming a complex of homo- and heterodimers
(Adams and Cory 1998). The relative ratios of anti- and pro-apoptotic Bcl-2 family proteins
are responsible for the fate of cells (Reed 2000). Bcl-2 was first discovered as a protooncogene in B cell lymphomas (Saikumar et al. 1999). It causes oncogenesis by suppressing
apoptosis rather than by stimulating rapid cell division. Apoptosis inhibition by Bcl-2 overexpression occurs by growth factor withdrawal, glucocorticoid treatment, chemotherapeutic
agents, gamma-radation of thymocytes, and hypoxia of kidney cells (Saikumar et al. 1999).
In humans, there are approximately 20 members of Bcl-2 family genes that have been
described to date. The genes that encode anti-apoptotic proteins include Bcl-2, Bcl-xL, Mcl-1,
Bfl-1(A1), Bcl-W, and Boo (Diva) and those that encode pro-apoptotic proteins are Bax, Bak,
Bok (Mtd), Bad, Bid, Bim, Bik, Hrk, Bcl-XS, APR (Noxa), p193, Bcl-G, Nip3, and Nix
(BNIP) (Adams and Cory 1998; Saikumar et al. 1999; Reed 2000). Sequence comparisons on
a majority of Bcl-2 family proteins have revealed up to four conserved areas, BH (Bcl-2
homology) domains: BH1, BH2, BH3, and BH4. The other subset of Bcl-2 family proteins
commonly has only the BH3 domain. Those are Bad, Bik, Bim, Hrk, Bcl-GS, p 193, and APR
(Noxa); all of them are pro-apoptotic proteins and their apoptotic activity depends on
dimerization with anti-apoptotic members such as Bcl-2 and Bcl-xL to create a pore (Kelekar
and Thompson 1998).
Many Bcl-2 family proteins are constitutively localized to the membranes of
mitochondria. For example, Bcl-2 and Bcl-xL have a group of hydrophobic C-terminal amino
acids, the transmembrane domain, which anchors the proteins in the outer membrane of
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mitochondria, while many pro-apoptotic proteins such as Bid, Bim, and Bad lack C-terminal
transmembrane domains and normally exist in the cytosol but can be induced in
mitochondrial membranes (Reed 2000). In the case of Bid, as activated caspase-8 cleaves the
N-terminal 52 amino acids, the BH3 domain and the hydrophobic core of the protein are
exposed (Schendel et al. 1999). Translocated, truncated Bid interacts with Bax and releases
cytochrome c (Li et al. 1998). Bax, a normally cytosolic protein, translocates to mitochondria
following exposure to various apoptotic stimuli (Saikumar et al. 1999). Bax is the only Bcl-2
family protein that has a C-terminal transmembrane domain but exists in the cytosol. In the
outer membranes of mitochondria, Bax is thought to assume an active conformation and/or to
interact with outer membrane proteins to form pores, releasing cytochrome c (Shimizu et al.
1999).
Bcl-2 and Bcl-xL are the representative anti-apoptotic Bcl-2 family proteins and the
most potent inhibitors of cell death yet discovered (Saikumar et al. 1999). They are located in
the outer membranes of mitochondria and inhibit apoptosis by preventing mitochondrial
permeabilization and the release of cytochrome c (Yang et al. 1997). In addition to
cytochrome c, anti-apoptotic Bcl-2 family proteins control the release of other pro-apoptotic
proteins from the mitochondria. These proteins include AIF (apoptosis inducing factor),
which induces apoptosis via a caspase-independent mechanism, and Smac/Diablo, an
inhibitor of IAPs (inhibitors of apoptosis proteins; Reed 2000).
4. Inhibitors of Apoptosis Proteins
There are endogenous inhibitors of apoptosis other than anti-apoptotic Bcl-2 family
proteins. A structurally distinct group of proteins that block apoptosis has been identified in
the cytosol and referred as inhibitors of apoptosis proteins (IAPs) (Saikumar et al. 1999).
IAPs can function as “suicide substrates” for caspases by neutralizating caspase-mediated
cleavage (Patston et al. 1991). Expression of survivin, a human IAP, correlates with
decreased apoptosis and oncogenic transformation (Ambrosini et al. 1997).
5. Protein Degradation and DNA Fragmentation
Early proteolytic events, which are mainly associated with activated initiator caspases,
include cleavage of fodrin (an abundant membrane-associated cytoskeletal protein), vimentin,
and actin (Hupperz et al. 1999). The cleavage of cytoskeletal proteins and modification of
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cytoplasmic proteins like myosin result in shrinkage of the cell and blebbing of the cell
surface (Mills et al. 1998). The flip of phosphatidylserine from the inner to the outer leaflet
of the plasma membrane of cells is another early apoptosis event (Martin et al. 1995). In
normal conditions, aminophospholipids such as phosphatidylserine or
phosphatidylethanolamine are confined to the inner leaflet of the plasma membrane while
neutral phospholipids such as phosphatidylcholine are in the outer leaflet. This composition
is maintained by the ATP-dependent aminophospholipid translocase. In the early stage of
apoptosis, activated initiator caspases inhibit the translocase activity as well as activate
translocating proteins (scramblases or floppases), resulting in the accumulation of
phosphatidylserine in the outer leaflet of plasma membrane (Hupperz et al. 1999). The
translocated phosphadidylserines serve as a recognition signal of apoptotic cells for
phagocytes (Savill 1998).
In the later stage of apoptosis, activated execution caspases cleave a variety of
cytoplasmic and membrane proteins including α- and β-catenin and focal adhesion kinase by
caspases-3 and -6, and intermediate filament cytokeratin 18 by caspases-3, -6, and -7
(Hupperz et al. 1999). The principle targets of the execution caspases, however, are nuclear
proteins including nuclear envelope proteins: lamin A, B, and C, poly-(ADPribose)polymerase (PARP), and endonucleases. Lamins are the major structural proteins of
the nuclear envelope and generally are cleaved by caspase-6 (Hupperz et al. 1999). PARP is
a DNA repair enzyme and inhibits Ca2+/Mg2+-dependent endonucleases, which cleave DNA
during apoptosis (Tanaka et al. 1984). Therefore, the cleavage by caspases results in reduced
DNA repair and increased chance of DNA damage. In addition, execution caspases activate
endonucleases, which are responsible for a highly characteristic pattern of DNA
fragmentation, producing typical DNA ladder in agarose gel.
6. Phagocytic Recognition
Interactions between apoptotic cells (apoptotic bodies) and phagocytes are not fully
understood, but a series of molecules seem to be important in the apoptotic cells. These
molecules include phosphatidylserin, anionic phospholipids in the outer leaflet of the plasma
membrane (Savill 1997), and intercellular adhesion molecule 3 (ICAM 3; Moffatt et al.
1999). Key recognition molecules on the phagocytes include CD14 (which partners ICAM
3), CD36, and vitronectin receptor (αvβ3 integrin). Both CD36 and vitronectin receptor bind
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a bridging molecule, thrombospondin, which seems likely to link with phosphatidylserine on
the apoptotic cell membrane (Afford and Randhawa 2000).
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CHAPTER II: CHONDROCYTE APOPTOSIS IN EQUINE OSTEOARTHRITIS
Introduction
Joint pain and loss of mobility caused by osteoarthritis (OA) are common causes of
poor performance and early retirement in equine athletes (Todhunter and Lust 1992).
Traumatic injury is believed to be a common cause of OA. It may be single event trauma,
arising from a clearly definable injury to joint structures, or more insidious, repetitive,
traumatic insults. Development of OA in horses is often associated with the stresses of racing
and training (Cantley et al 1999), rendering the supports to the idea that mechanical stress is
the major cause of OA.
Loss of articular cartilage and fibrillation are the most striking features of OA within
the cartilage. This fact has lead most arthritis-related research to study the changes within
extracellular matrix. Little attention has been given to the role of chondrocyte survival or
death. Recent studies using electron microscopy, flow cytometry, and DNA fragmentation
assay (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling; TUNEL
assay) have shown that apoptosis is the major pathway of chondrocyte death in the human
articular cartilage of OA (Blanco et al. 1998, Hashimoto et al. 1998a, Hashimoto et al. 1998b,
Hashimoto et al. 1998c, Lotz et al. 1999). Recently, chondrocyte apoptosis has received
more attention in pathogenesis of OA because chondrocytes are the only cells existing within
and maintaining the extracellular matrix in the articular cartilage.
Nitric oxide (NO) has been implicated as an important biological mediator of OA. NO
production from chondrocytes is significantly higher in OA cartilage compared with that in
the control, and directly correlates with the severity of OA (Hashimto et al. 1998c; Spreng et
al. 2000). The major source of endogenous NO in chondrocyte is inducible nitric oxide
synthase (iNOS). Experimental treatment with selective inhibitors against iNOS has
significantly reduced the progression of OA in vivo (Pelletier et al. 1998; Pelletier et al. 2000).
NO reacts with the superoxide radical to form peroxynitrite. In tissues or biologic fluids,
peroxynitrite leads to the nitration of aromatic amino acid residues, and the presence of such
nitration can be used as a marker of peroxylnitrite-mediated NO action in vivo (Beckman
1994).
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No studies have been done on chondrocyte apoptosis in equine osteoarthritis. The
present study investigated chondrocyte apoptosis in the articular cartilages from horses with
OA and examined the relationship between chondrocyte apoptosis and cartilage degeneration.
In addition, a possible link between chondrocyte apoptosis and endogenous NO production
was examined.
Materials and Methods
Equine Articular Cartilage
Cartilage was obtained from articular surfaces of the distal metacarpal or metatarsal
bones from 8 horses (age range from 2 to 7 years): 5 horses with OA and 3 normal horses.
The horses had been submitted for either postmortem examination or for other non-jointrelated research. Full-thickness slices of cartilage specimens were harvested within 3 hours of
death.
Histopathologic Evaluation
The cartilage specimens were fixed in 10% neutral buffered formalin, processed by
standard procedures, embedded in paraffin, sectioned (4 µm), and stained with hematoxylin
and eosin for histopathologic evaluation. The histopathologic evaluation criteria originally
proposed by van der Sluijs et al. (1992) were used with slight modification (Table 2.1). Since
the calcified layer of articular cartilage and underlying subchondral bone were not included in
the cartilage specimens, one of the evaluation criteria, “Tidemark integrity”, was not
considered. Also, when fissures reached to the deep layer of articular cartilage instead of
calcified layer as originally proposed, the damage was considered to be enough to score 5.
The severity of OA was represented by a combined total score (0-9) assessing structural
damages (0-6) and cellular abnormalities (0-3).
In situ Detection of Chondrocyte Apoptosis
Chondrocyte apoptosis was identified with an immunohistochemical method (TUNEL
method) using the ApopTag® peroxide In Situ Apoptosis Detection Kit (Intergen, Purchase,
NY). Tissue sections were pretreated with 3% hydrogen peroxide for 5 minutes and digested
with proteinase K (DAKO® Proteinase K Ready-to-Use; DAKO, Carpinteria, CA) for 10
minutes at room temperature. DNA fragments were end-labeled with digoxigenin-labeled
dUTP using terminal transferase, and were detected with perioxidase-conjugated
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antidigoxigenin antibody. Diaminobenzidine tetrahydrochloride (DAB) was used as the
chromogen and the signal was amplified with additional incubation in 0.5% copper sulfate
solution for 5 minutes at the room temperature. For counter-staining, 0.5% methyl green in
0.1M sodium acetate for 10 min was applied.
Table 2.1. Histopathologic criteria for osteoarthritis
Criteria

Score

Structure
Normal
Irregular surface, including fissures into the middle layer
Pannus
Superficial cartilage layers absent
Slight disorganization (cellular rows absent, some small
superficial clusters)
Fissures into deep cartilage layer
Disorganization (chaotic structure, clusters, osteoclast activity)
Cellular abnormalities
Normal
Hypercellularity, including small superficial clusters
Clusters (cloning)
Hypocellularity
Total

0
1
2
3
4
5
6
0
1
2
3
0-9

Immunohistochemistry for Nitrotyrosine
The tissue sections were pretreated with proteinase K (DAKO® Proteinase K Readyto-Use; DAKO, Carpinteria, CA) for 10 minutes at the room temperature and then with 3%
hydrogen peroxide for 5 minute at the room temperature. The distribution of nitrotyrosine
was determined with the avidin-biotin-peroxidase (ABC) method using VECTASTAIN® Elite
ABC-Peroxidase Kit (Vector Laboratories, Burlingame, CA). Rabbit polyclonal antibody to
nitrotyrosine (Upstate Biotechnology, Lake Placid, NY) was used as the primary antibody.
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The negative control consisted of nonimmune rabbit serum as a substitute for the primary
antibody.
Data Analysis
The Kruskal-Wallis non-parametric ANOVA was used to evaluate statistical
differences in histopathologic scores and percentage of chondrocyte apoptosis between
normal and OA cartilages. The correlation between histopathologic grades and chondrocyte
apoptosis was analyzed with Spearman rank correlation test. Statistical significance was
established at 95% confidence interval (p < 0.05).
Results
Histopathologic Evaluation
All control horses had grossly normal articular cartilage surfaces, while the OA horses
had rough, often slightly yellow and dull, fibrillated articular surfaces. All cartilage
specimens from normal horses had no or minimal microscopic changes with a score of 0 or 1
(median = 1). The only microscopic change observed was mild articular surface irregularity,
but no cellular abnormalities were noted (Figure 2.1). OA cartilages, however, showed a
wide range of structural alterations as well as cellular abnormalities. The structural changes
ranged from irregular surface to fibrillation into deep cartilage layers but none of the OA
cartilages showed chaotic structural disorganization. The cellular abnormalities included
multifocal areas of hypercellularity in the superficial layers and clustering (cloning) of
chondrocytes in the fibrillated articular surface as well as along the fissures in the deep layers
(Figure 2.2). OA cartilages had a score of 6 or 7 (median = 7). The histopathologic scores of
OA cartilages (6.6 ± 0.55; mean ± SD) were significantly higher than those from the normal
cartilages (0.67 ± 0.58) (p = 0.004).
Chondrocyte Apoptosis
The percentage of apoptotic chondrocytes in the OA cartilage was significantly higher
than that in the normal articular cartilage (p=0.008) (Table 2.2). Because the cartilage
specimens collected from the articular joints did not consistently contain the deep layer and
chondrocyte apoptosis mainly occurred in the superficial and middle layers, apoptotic
chondrocytes were counted only in the superficial and middle layers. The percentage of
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Figure 2.1. Equine normal articular cartilage. No microscopic abnormalities are noted.

Figure 2.2. Articular cartilage from an osteoarthritic horse. Note the severe fibrillation of the
articular surface and chondrocyte clustering (cloning).
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apoptotic chondrocytes in the normal cartilages (Figure 2.3) ranged from 2 to 5.3 % (3.3 ± 1.7
%; mean ± SD). In contrast, the OA cartilages (Figures 2.4 and 2.5) contained frequent
apoptotic chondrocytes, ranging from 20.8 to 39.7 % (32.6 ± 9.1%). Because the superficial
layers of all OA cartilages were diffusely effaced, especially in the areas of fibrillation, most
counted chondrocytes were located in the middle layer. For detailed analysis, apoptotic
chondrocytes were counted separately in the lesional (fibrillation) and in non-lesional areas of
OA cartilage specimens. Although statistically not significant, the percentage of apoptotic
chondrocytes in the lesional areas (35.8 ± 9.6 %) was higher than the non-lesional areas (26.9
± 4.4 %) (p = 0.07).

Table 2.2. Percentage of apoptotic cells in equine articular cartilage (mean ± SD)
Character of cartilage

Percentage of apoptotic cells
3.3 ± 1.7

Normal cartilage (n=3)

32.6 ± 9.1a

Overall
OA
cartilage

Lesion

35.8 ± 9.6b

Non-lesion

26.9 ± 4.4

(n=5)

a
b

p= 0.008; Kruskal-Wallis ANOVA, vs. normal cartilage
p=0.07; Kruskal-Wallis ANOVA, vs. non-lesional OA cartilage
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Figure 2.3. TUNEL staining for detecting DNA fragmentation in equine normal articular
cartilage. No cells with positive immunoreactivity are noted.

Figure 2.4. TUNEL staining for detecting DNA fragmentation in equine osteoarthritic
articular cartilage. Note positive immunoreactivity in the clusters of chondrocytes in the areas
of fibrillation.
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Correlation between Histopathologic Grade and Chondrocyte Apoptosis
There was a significant correlation between histopathologic grade and apoptotic
chondrocyte numbers in OA cartilage (p < 0.001) (Figure 2.5).
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Figure 2.5. Correlation between histopathologic grade and chondrocyte apoptosis (p<0.001).

Detection of Nitrotyrosine
The normal articular cartilages showed mild immunostaining limited to the
chondrocytic cytoplasm and the pericellular matrix immediately adjacent to the chondrocytes
in the superficial and upper middle layers (Figure 2.6). The OA cartilages exhibited intensely
stained chondrocyte cytoplasm and cartilage matrix in a diffuse pattern. The positive
immunoreactivity was present not only in the superficial and middle layers but also in the
deep layer in the areas of fibrillation (Figure 2.7). The distribution of intense nitrotyrosine
immunoreactivity in the OA cartilages paralleled that of chondrocyte apoptosis.
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Figure 2.6. Immunohistochemistry for nitrotyrosine in equine normal articular cartilage.
Positive immunoreactivity is limited to the chondrocytic cytoplasm and the pericellular matrix
in the superficial and upper middle layers.

Figure 2.7. Immunohistochemistry for nitrotyrosine in equine osteoarthritic articular cartilage.
Note intensely positive immunoreactivity of the chondrocytes as well as cartilage matrix in a
diffuse pattern in the areas of fibrillation.
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Discussion
Osteoarthritis is the most common disease of equine joints. Musculoskeletal disorders
including OA are leading causes of morbidity in the athletic horses. It has been reported that
84.6% of injuries in the racehorses were related to the musculoskeletal system (Johnson
1991). Approximately 90% of those injuries were in forelimbs, frequently involving
metacarpophalangeal (fetlock) and carpal joints (Rossdale et al. 1985). These injuries are
considered to be related to the stresses resulting from excessive joint motion and excursion
due to uneven ground, excessive training, immaturity, poor conformation, or improper
shoeing (McIlwraith and Trotter 1996). It is believed that initial cartilage damage caused by
mechanical trauma leads to progressive cartilage deterioration.
Chondrocyte apoptosis in OA cartilage has been reported in dogs and humans (Blanco
et al. 1998; Hashimoto et al. 1998a; Hashimoto et al. 1998c; Pelletier et al. 1998; Kim et al.
2000). Human OA is age-related and the pathologic changes include decreases in
chondrocyte cellularity in the cartilage and increases in empty lacunae. Chondrocyte
apoptosis is considered to be one of the major causes of these age-related pathologic changes
and is correlated with incidence of osteoarthritis (reviewed by Hashimoto et al. 1998c).
Chondrocytic death by means of apoptosis has been reported in normal human cartilage and
even in young people (Blanco et al. 1998; Hashimoto et al. 1998a; Kim et al. 2000). The
pathogenesis of the age-related apoptosis is not fully understood. Recently, Chen et al. (2001)
reported that chondrocyte apoptosis was observed in mechanical impact-damaged articular
cartilage. It is possible that the increased apoptosis in the aged population may result from
continuous mechanical stress on the articular joints during their lifespan. As an extension of
this hypothesis, OA in young horses subjected to intense training could be, at least in part,
directly associated with chondrocytic apoptosis initially caused by mechanical stresses.
In this study, we found that the number of apoptotic chondrocytes in OA cartilage was
significantly higher than that in normal cartilage in horses. This observation is similar to the
findings in human OA and in experimentally induced canine OA (Blanco et al. 1998;
Hashimoto et al. 1998a; Hashimoto et al. 1998c; Pelletier et al. 1998; Kim et al. 2000). Kim
et al. (2000) reported that within the same human OA cartilage, apoptotic chondrocytes were

27

noted more frequently in the lesional area than in the non-lesional area. A similar result was
also obtained from the equine articular cartilages with OA in the present study.
Our investigation showed that chondrocyte apoptosis and degradation of articular
cartilage were closely correlated. High incidence of chondrocyte apoptosis occurred in the
severely degraded cartilage matrix. Whether chondrocyte apoptosis is a cause of or the result
of cartilage breakdown is one of the pivotal questions in OA pathogenesis. Degradation of
extracellular matrix could contribute to the loss of a survival signal for chondrocytes. Also,
biological mediators, such as NO, cytokines, or proteinases (e.g. matrix metalloproteinases),
from chondrocytes themselves or from other damaged chondrocytes, could directly or
indirectly trigger apoptosis. Alternatively, chondrocyte apoptosis could cause the matrix
degradation because chondrocytes are the only cells that exist in the cartilage and that
maintain the extracellular matrix.
Excessive production of NO has been linked to cartilage catabolism (Hauselmann et
al. 1998; Pelletier et al. 1998; Spreng et al. 2000) and chondrocyte apoptosis (Hashimoto et al.
1998c; Blanco et al. 1998; Hashimoto et al. 1999). We indirectly demonstrated NO produced
by equine chondrocytes with polyclonal antibody to nitrotyrosine. Equine OA articular
cartilage had more intense and diffuse positive immunoreactivity than the normal cartilage.
In addition, strong positive reactivity was observed in the areas of degraded extracellular
matrix, where frequent chondrocyte apoptosis was noted. In the marginal areas of fibrillation,
the strong immunoreactivity corresponded with the high percentage of chondrocyte apoptosis
as well.
The topographical distribution of matrix degradation, chondrocyte apoptosis, and NO
production were almost completely overlapping in the equine OA articular cartilage,
suggesting that these pathological phenomenons are closely interrelated.
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CHAPTER III: CYCLIC HYDROSTATIC PRESSUE INDUCES EQUINE
CHONDROCYTE APOPTOSIS
Introduction
Decreased cellularity of chondrocytes is one of the characteristic features of
osteoarthritis (OA) (Stockwell 1971, Lust and Summers 1981, Buckwalter and Mankin 1998).
Recent studies strongly suggest that the loss of cellularity in the articular cartilage with OA is
due to in situ chondrocyte apoptosis (Blanco et al. 1998, Hashimoto et al. 1998a, Kim et al.
2000). Preservation of cell viability in articular cartilage is essential to matrix metabolism,
tissue repair, and the prevention of OA, because the chondrocyte is the only cell that exists in
articular cartilage.
Articular cartilage is a load-bearing tissue and mechanical stress is believed to be a
major factor of OA (Burton-Wurster et al. 1993, Lee et al. 1998, Steinmeyer et al. 1999a,
Steinmeyer and Ackermann 1999b). OA can be categorized into two groups based on the
etiology (Buckwalter and Mankin 1998). The primary OA is the most common OA in human
and is often idiopathic. The secondary OA results from previous trauma or infection. Some
investigators have suggested that the primary OA may also result from insidious joint injury
(Kraus 1997, Buckwalter and Mankin, 1998).
In vivo OA experiments have demonstrated that the mechanical stress is responsible
for chondrocyte apoptosis, the degree of which is closely correlated with matrix degeneration
(Hashimoto et al. 1998c; Pelletier et al. 1998). Recently, in vitro studies have shown that a
repetitive high impact mechanical loading on bovine articular cartilage explants induces
chondrocyte apoptosis, and the number of apoptotic cells was correlated with the frequency,
strength, and duration of applied mechanical pressure (Loening et al 2000, Chen et al 2001,
Clements et al 2001). Loening and colleagues (2000) reported that chondrocyte apoptosis
occurred without any matrix alteration after applying mechanical pressure on the cartilage
explants, suggesting that chondrocyte apoptosis may be one of the earliest responses to the
cartilage damage, and may precede and be the cause of matrix degradation.
A few in vitro studies using chondrocytes have been carried out on mechanical stressrelated chondrocyte metabolism (Das et al. 1997; Lee et al. 1998a; Hutton et al. 1999), but
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there have been no in vitro studies focused on chondrocyte apoptosis using chondrocytes
under a cyclic high pressure.
The present in vitro experiment using equine chondrocytes in a novel pressure loading
system demonstrated that cyclic hydrostatic high pressure directly induces chondrocyte
apoptosis.
Materials and Methods
Equine Chondrocyte Isolation
Cartilage was obtained from articular surfaces of the distal metacarpal or metatarsal
bones from 4 young horses (2 to 4 years old). The articular cartilage was grossly normal and
the horses had no history of joint-related disease. The horses had been submitted for either
postmortem examination or for other non-joint-related research. The cartilage specimens were
collected within 3 hours of death. The joints were aseptically disarticulated and, with a scalpel
blade, the superficial and deep layers of articular cartilages of metacarpal or metatarsal bones
were separately harvested and placed in chilled PBS (pH 7.4) in petri dishes. The collected
cartilage slivers were finely minced into 1mm or less pieces and incubated in Ham’s
F12/DMEM medium (Life Technologies, Grand island, NY) containing filter-sterilized
collagenase II (final concentration of 3mg/ml; Worthington Biochemical Corporation,
Lakewood, NJ) overnight in an incubator (37C, 5% CO2, in a humidified atmosphere).
Construction of Alginate Beads
The remaining small fragments of cartilage were removed by gently and slowly
passing the chondrocyte suspension through layers of autoclaved gauzes. The filtered cell
suspension was centrifuged at 500x g for 10 minutes and the supernatant was discarded. The
pelleted cells were washed twice more with sterile saline. A small amount (20 µl) of the cell
suspension aliquot was collected and the total number of the cells was estimated by using a
hemocytometer and cell viability was examined after staining with trypan blue. The rinsed
chondrocytes were suspended in saline containing 1.2% (v/v) alginic acid (sodium salt;
Sigma, St. Louis, MO) to yield a final concentration of 1.5 x 106 cells/ml. By using a syringe,
the cell suspension was slowly expressed through a 22-gauge needle into a 102 mM CaCl2
solution in 6-well cell culture plates, producing polymerized, regularly-sized, 3 dimensional
constructs, “beads”. After polymerization in the CaCl2 solution for 10 minutes, the
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chondrocyte-laden beads were rinsed with sterile saline 3 times, and with Ham’s F12/DMEM
twice, and incubated in the complete Ham’s F12/DMEM medium including antibiotics and
10% fetal bovine serum (Life Technology, Grand island, NY) until the pressure loading
experiment (within 7 days). The medium was replaced every two days.
Application of Hydrostatic Pressure
The pressure loading system consisted of two HPLC glass columns, an isocratic
HPLC pump, and a metering valve (Figure 3.1). Superficial and deep layer chondrocytes
embedded in alginate bead constructs were separately installed in the HPLC glass columns
(AP glass column; Waters, Milford, MA) that were connected with an isocratic HPLC pump,
and then pressurized at 1,000 ± 100 psi (approximately 6.8 ± 0.6 MPa). The pressure protocol
consisted of repeated, 15 minute each on-off cycles for 12 hours. The peak pressure was
reached within one minute in each cycle. The complete cell culture medium in the system was
continuously recirculated throughout the experimental period. The chondrocyte-loaded
HPLC columns and the complete culture medium were placed in a cell culture incubator at 37
°C in a humidified atmosphere with 5% CO2. The pressure was carefully controlled with a
metering valve (Hoke Fine Metering Valve; Alltech, Deerfield, IL) at a flow rate of 1.5 ± 0.2
ml/min. The culture medium continuously flowed in the system throughout the experimental
period, even during off-cycles. For the controls, cell culture dishes containing chondrocytes
from superficial and deep layers were placed next to the glass columns in the incubator. After
being pressurized, the chondrocyte-laden alginate bead constructs were collected from the
HPLC columns and placed in the incubator for 36 hours.
Immunocytochemistry for Chondrocyte Apoptosis
The chondrocytes were isolated from the dissolved alginate beads by treating with EDTA
(final concentration of 25 mM for 10 minutes) and washed twice with saline. Numbers of
isolated chondrocytes in each group were counted with a hemocytometer. Approximately 5 x
104 cells from each group were adhered to a glass slide by cytospin, fixed in chilled 1%
paraformaldehyde for 10 minutes, air-dried, and stored at –70C for later use (within 2 days).
Chondrocyte apoptosis was identified with an immunocytochemical method (TUNEL) using
the ApopTag® peroxide In Situ Apoptosis Detection Kit (Intergen, Purchase, NY).
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Figure 3.1. Hydrostatic pressure loading system. The system was composed of two HPLC
glass columns containing chondrocyte-seeded alginate beads, an isocratic HPLC pump, and a
metering valve. The chondrocytes were pressurized at 1,000 ± 100 psi (approximately 6.8 ±
0.6 MPa). The pressure protocol consisted of repeated, 15 minute each on-off cycles for 12
hours. The pressure was controlled by the metering valve and flow rate of cell culture
medium (1.5 ± 0.2 ml/min) by the pump.
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The chondrocytes on the glass slides were pretreated with 3% hydrogen peroxide for 5
minutes followed by 0.5% Triton X-100 for 10 minutes. DNA fragments were labeled with
digoxigenin-labeled dUTP using terminal trasferase, and were detected with peroxidaseconjugated antidigoxigenin antibody. Diaminobenzidine tetrahydrochloride (DAB; Sigma, St.
Louis, MO) was used as the chromogen for detection and the signal was amplified with
additional incubation in 0.5% copper sulfate solution for 5 minutes at the room temperature.
For counter-staining, 0.5% methyl green in 0.1M sodium acetate for 10 minutes was applied.
Quantification of Chondrocyte Apoptosis and Statistical Analysis
Total numbers of chondrocytes (approximately 1,000 cells per slide) were counted in
five, randomly selected, 400 X microscopic fields per slide with a digital image analyzing
system (Image Pro® Plus, Media Cybernetics). Positively stained cells within these fields were
counted manually. The cells were considered positive when their nuclei were stained or
completely surrounded by the chromogen. The SAS statistical package (GLM procedure) was
used to analyze the data. The chondrocyte apoptosis data and the data of relative increase
ratios of control and treatment groups were normalized by log transformation. The logtransformed data were analyzed by an analysis of variance in a Randomized Block Design.
For chondrocyte apoptosis analysis, the blocking factor was horse. The pressure-loading
treatment and cartilage layer served as effects in the model and treatment*cartilage layer were
examined for interactions. For analysis on the apoptosis increase ratio, the blocking factor
was horse and the main effect was cartilage layer in the model. Pairwise comparisons were
conducted with the LSMEANS option to obtain t-tests. All comparisons were considered
significant at p≤ 0.05.
Results
Chondrocyte apoptosis occurred more frequently in the pressure-loaded chondrocytes
of equine articular cartilage compared with the control (p < 0.001) (Table 2.1) (Figures 2.2 2.5). Significantly higher percentages of apoptosis occurred in the pressure-loaded
chondrocytes of both the superficial and deep layers than in the corresponding control groups.
Within the control groups, chondrocytes from the deep layers showed greater apoptosis than
those from the superficial layers (p=0.003). The cyclic hydrostatic pressure induced more

33

apoptosis in the chondrocytes from the superfiical layers than those from the deep layers
(p<0.001) (Table 2.2).

Table 3.1. Apoptosis of pressure-loaded and control chondrocytes isolated from superficial
and deep layers of equine articular cartilage (mean ± SD)
Percentage of apoptotic chondrocytes
Horse

Pressure loadeda

Control

PSb (n=5)

PDc (n=5)

CS (n=5)

CDd (n=5)

1

3.49 ± 0.72

4.74 ± 1.78

0.80 ± 0.39

2.54 ± 1.02

2

3.38 ± 1.26

4.19 ± 1.65

1.82 ± 1.37

2.82 ± 1.15

3

3.33 ± 0.77

6.18 ± 1.17

0.97 ± 0.93

1.44 ± 1.50

4

9.08 ± 2.72

7.54 ± 2.91

1.87 ± 1.11

2.10 ± 0.72

PS: Pressure-loaded chondrocytes from superficial layer
PD: Pressure-loaded chondrocytes from deep layer
CS: Control chondrocytes from superficial layer
CD: Control chondrocytes from deep layer
a

: Pressure-loaded vs. control; p <0.0001
: PS vs. CS; p<0.0001
c
: PD vs. CD; p<0.0001
d: CS vs. CD; p=0.0003
b
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Table 3.2. Relative increase of chondrocyte apoptosis in the pressure-loaded experimental
groups compared with the corresponding control groups (mean ± SD)
Horse

PS/CS* (n=25)

PD/CD (n=25)

1

5.46 ± 2.83

2.43 ± 1.93

2

2.69 ± 1.77

1.74 ± 1.03

3

3.52 ± 1.95

4.29 ± 2.07

4

6.12 ± 3.07

4.03 ± 2.14

PS: Pressure-loaded chondrocytes from superficial layer
CS: Control chondrocytes from superficial layer
PD: Pressure-loaded chondrocytes from deep layer
CD: Control chondrocytes from deep layer
Mean ± SD was calculated from all possible combinations of apoptosis percentages from 5
randomly selected microscopic areas of each experimental and control group.
*: PS/CS vs. CD/PD; p<0.0001
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Figure 3.2. TUNEL staining for detection of apoptotic chondrocytes. The control
chondrocytes that were isolated from superficial layers of equine articular cartilage and were
not subjected to pressure. No chondrocytes are positively stained.

Figure 3.3. TUNEL staining for detection of apoptotic chondrocytes. The chondrocytes were
isolated from superficial layers of equine articular cartilage and pressured with a cyclic
hydrostatic pressure of 6.8 MPa for 12 hours. Note increased apoptotic chondrocytes over the
control.
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Figure 3.4. TUNEL staining for detection of apoptotic chondrocytes. The control
chondrocytes that were isolated from deep layers of equine articular cartilage and were not
subject to pressure. A few chondrocytes shows immunopositivity.

Figure 3.5. TUNEL staining for detection of apoptotic chondrocytes. The chondrocytes were
isolated from deep layers of equine articular cartilage and pressured with a cyclic hydrostatic
pressure of 6.8 MPa for 12 hours. Note increased apoptotic chondrocytes over the control.
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Discussion
The cyclic hydrostatic pressure-loaded chondrocytes had a higher percentage of
apoptosis than the control, suggesting that mechanical pressure could directly induce
apoptosis of chondrocytes. Several in vivo (Hashimoto et al. 1998c; Hashimoto et al. 1999;
Pelletier et al. 2000) and in vitro (Loening et al. 2000, Tew et al. 2000; Chen et al. 2001,
Clements et al. 2001) experiments have demonstrated that increase in chondrocyte apoptosis
can be induced by direct pressure impact on articular cartilage explants or by joint
malalignment created by surgical anterior cruciate ligament transection. Loening and
colleagues (2000) suggested that mechanical compression could directly induce chondrocyte
apoptosis by demonstrating apoptotic chondrocytes without any sign of matrix degradation in
the pressurized articular cartilage explants. There was still a possibility that the apoptosis was
not a direct result from the pressure load but a secondary consequence from undetected,
disrupted extracellular matrix due to the compression. Bendele and White (1987) observed
the loss of fine granular material interspersed between collagen fibers in the superficial layer
of articular cartilage as early as 24 hours after surgery in meniscectomized guinea pigs and
disorganized collagen fibrils surrounding chondrocytes at 96 hours after surgery. Integrinmediated attachment to extracellular matrix is crucial for chondrocyte survival (Loester 1993;
Hirsch et al. 1997; Wright et al. 1997). Integrins are the chondrocytic transmembrane
proteins that mediate chondrocyte adhesion to the extracellular matrix by interacting with
fibronectins. Integrin α5β1 is most commonly expressed in human cartilage and believed to
be a chondrocyte mechanoreceptor (Wright et al. 1997). Therefore, disruption of extracellular
matrix by mechanical impact could cause chondrocyte apoptosis via dissociation of
chondrocyte integrins from the extracellular matrix. Another possible factor for chondrocyte
apoptosis in long-term experiments might be an elevated accumulation of fibronectin
fragments. Accumulated fibronectin fragments are commonly found on the articular cartilages
in human OA patients (Xie et al. 1992; Jones et al. 1987) and have been demonstrated in
articular cartilage explants after cyclic mechanical impact (Farquhar et al. 1996). Fibronectin
fragments induce matrix degradation by chondrolysis from up-regulated metalloproteinases
(Homandberg et al. 1992) and by chondrocyte catabolism resulted from suppressed
proteoglycan synthesis (Homandberg et al. 1993; Homandberg 1999). Xie and colleagues
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(1993), however, suggested that fibronectin fragments did not directly cause chondrocyte
death based on the measurements of tissue DNA content. This method is not considered to be
appropriate to detect early apoptosis, however.
Apoptotic chondrocytes are often located in the superficial and upper middle layers of
OA cartilage as well as in normal cartilage (Blanco et al. 1998; Hashimoto et al. 1998c). We
demonstrated that a relative increase of apoptotic chondrocytes after the pressure loading was
observed more in the superficial chondrocytes compared with the chondrocytes from deep
layers. This finding is parallel to the results of the previous studies. Conversely, a higher
percentage of apoptosis was noted in the control chondrocytes in deep layers than in those
from superficial layers. Tew and colleague (2000) have shown that chondrocyte apoptosis
increases at the edges of the mechanically wounded articular cartilages. Since the deep
cartilage layer is much thicker than the superficial layer, it is possible that it received more
physical damage than the superficial layer when cartilage specimens were minced with
scalpel blades during sample preparation. This may explain why more frequent apoptosis
occurred in the control deep layer chondrocytes than the control superficial layer
chondrocytes.
This study demonstrated that a cyclic hydrostatic pressure of 1,000 ± 100 psi
(approximately 6.8 ± 0.6 MPa) for 12 hours could induce chondrocyte apoptosis. Clements
and colleagues (2000) observed that there was a threshold (6 MPa) of mechanical pressure to
induce chondrocytic death; cell viability was inversely proportional to the applied pressure
greater than 6 MPa. Loening and colleagues (2000) showed that repetitive compressive
pressure as low as 4.5 MPa could cause chondrocyte apoptosis after six repetitive
compression cycles in 3 hours.
Recently, contact pressure on the proximal articular cartilage of the equine proximal
phalanx was measured with pressure sensitive sheets inserted between the articular surfaces
(Brama et al. 2001). The contact pressure reaches 30-35 MPa, when a horse gallops and
jumps, with maximum range of 40 to 45 MPa. These observed values appeared to be beyond
the physiological pressure limit, which is approximately 20 MPa (Mow et al. 1999). The peak
magnitude of the principal effective stress could be as low as 14 % of the peak contact stress
at the articular surface (Ateshian et al. 1994). In a human patient, a pressure-measuring
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Moore-type endoprosthesis that was implanted in a hip joint measured an 18 month postsurgical maximum pressure of 8.9 MPa when rising from a chair and 5.4 MPa when walking
(Hodge et al. 1989). Therefore, our loading pressures of 6.8 Mpa are clinically relevant.
Articular cartilage is saturated with water. The water phase of cartilage constitutes
65% to 85% of the total tissue weight (Amstrong and Mow 1982; Setton et al. 1999). In the
joints, high loads during weight bearing are predominantly transmitted via the hydrostatic
pressure of the interstitial fluid of articular cartilage (Ateshian et al. 1994; Mow et al. 1999).
In this study, we simulate this by pump-generated hydrostatic pressure. Culture medium
flowed through the system continuously throughout the experimental period, even during the
pressure-off cycles, at a flow rate of 1.5 ± 0.2 ml. Since the diameter of the glass columns
was 10 mm, the flow rate within the HPLC columns was as low as approximately 0.32 ± 0.04
mm/sec. Therefore, the effect of shear stress within the experimental groups should not be
significant.
Biochemical and structural properties of articular cartilage vary and depend on the
topographical location, even in the same joint surface (Arokoski et al. 1999; Brama et al.
1999; Brama et al. 2000). Articular cartilage explants used in in vitro experiments may have
a heterogeneity in anatomical and biochemical properties even if the specimens were
consistently and carefully harvested from the same areas of the joint surfaces. In our in vitro
system, since chondrocytes were separately collected from superficial and deep layers and
homogenized during the preparation, the sample variation would be negligible.
If articular chondrocytes are cultured in monolayer environment, within hours, they
morphologically transform to fibroblast-like cells producing type I collagen instead of type II,
which is normally produced by mature chondrocytes (Green 1981; Benya and Shaffer 1982).
To maintain normal chondrocyte characteristics, three-dimensional chondrocyte culture
systems have been introduced with the scaffolds made of agarose gel, collagen, fibrin,
alginate, or biodegradable synthetic polymers (reviewed by Perka et al. 2000). Alginate is a
linear polysaccharide isolated from marine brown algae. The alginate solution instantly
becomes a gel in presence of divalent cations like calcium and is easily solubilized by
chelating agents, such as EDTA and citrate. Calcium alginate gels have been successfully
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applied to maintain chondrocytes in tissue culture (Lemare et al. 1998; Lindenhayn K et al.
1999; Perka et al. 2000).
The present study using a novel hydrostatic pressure loading system demonstrated that
chondrocyte apoptosis was directly induced by cyclic hydrostatic pressure, suggesting that
chondrocyte apoptosis may be an early change of OA and may directly contribute to matrix
degradation. This in vitro experimental system is useful to investigate physiological and
pathological changes of pressure-related chondrocyte metabolism.
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CHAPTER IV: INCREASED NITRIC OXIDE PRODUCTION AND BCL-2 AND
CASPASE-3 EXPRESSION BY EQUINE ARTICULAR CHONDROCYTES UNDER
CYCLIC HYDROSTATIC PRESSURE: LINKAGE TO CHONDROCYTE
APOPTOSIS
Introduction
Pathologically, osteoarthritis (OA) is characterized by extracellular matrix
degeneration and chondrocyte death. Recent studies indicate that chondrocyte death occurs
predominantly by means of apoptosis (Blanco et al. 1998). The level of apoptosis is
correlated with matrix breakdown (Blanco et al. 1998; Hashimoto et al. 1998a, 1998b, 1998c,
1999; Colwell et al. 2001), and chondrocyte apoptosis may result in matrix degeneration
(Hashimoto et al 1998c; Loening et al 2000).
Apoptosis is a particular form of cell death with specific morphological features of
condensed nuclei, membrane blebs, and apoptotic bodies separating from the apoptotic cells
(Saikumar et al. 1999; Afford and Randhaw 2000; Geske et al. 2001). Chondrocyte apoptosis
can be induced by various biochemical mediators including nitric oxide (NO) (Blanco et al.
1995; Kuhn and Lotz 2001; Teixeira et al. 2001), anti-Fas antibody (Hashimoto et al. 1997),
prostaglandin E2 (Miwa et al. 2000), tumor necrosis factor – alpha (Aizawa et al. 2001),
ceramide (Sabatini et al. 2000), and hydrogen peroxide (Asada et al. 2001). Mechanical
pressure load on articular cartilage is believed to be the major etiologic factor of OA and has
been demonstrated to induce ex vivo chondrocyte apoptosis in articular cartilage explants
(Loening et al 2000, Chen et al. 2001, Clements et al. 2001).
Apoptosis is frequently referred to as programmed cell death, which occurs by
precisely regulated activation of a series of preexisting death programs, which are encoded in
the genome. It is generally believed that control of apoptosis rests in the mitochondria (Finkel
2001). After exogenous death signals are received by various receptors on the cell membrane,
there is subsequent activation of caspase-8 and pro-apoptotic Bcl-2 families, such as BAX and
BAK, which cause release of cytochrome c from mitochondria into the cytoplasm. Released
cytochrome c triggers activation of executor caspases-3, -6, and/or -7 causing cell death
(reviewed by Huppertz et al. 1999; Saikumar et al. 1999; Geske et al. 2001; Finkel 2001).
NO is a free radical, acting as a pathophysiological mediator (Liaudet et al. 2000).
NO is mainly produced by inducible nitric oxide synthase (iNOS) in articular chondrocytes.
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Endogenous NO-induced chondrocyte apoptosis and the concentration of NO produced in the
cartilage correlated with the destruction of extracellular matrix in vivo (Blanco et al. 1998;
Hashimoto et al. 1998a, 1998c; Pelletier et al. 1998; Hashimoto et al. 1999). Although NO
production, detected in the form of nitrites, increases in mechanically compressed articular
cartilage explants (Loening et al. 2000), detailed mechanisms of how NO may initiate the
apoptosis cascade are not fully understood. Chemical NO donors cause release of cytochrome
c from mitochondria during HL-60 cell apoptosis (Yabuki et al. 2000) and activation of
caspase-3 (Lee et al. 2000; Teixeira et al. 2001; Kim et al. 2002) and caspase-7 (Lee et al.
2000) in chondrocyte apoptosis. Recent studies indicate that extracellular signal-regulated
protein kinase (ERK) –1/2 and p38 are linked to NO-induced apoptosis of chondrocytes
(Notoya et al. 2000; Kim et al. 2002). Kim and colleagues (2002) suggest that p38 functions
as an induction signal for apoptosis while ERK-1/2 operates as an anti-apoptotic signal.
Bcl-2 is one of a family of anti-apoptotic proteins that are located in the outer
membrane of mitochondria and prevent mitochondrial permeabilization and release of
cytochrome c (Yang et al. 1997). Bcl-2 expression is closely linked to chondrocyte apoptosis.
Expression of Bcl-2 is elevated in OA articular cartilage (Kim et al. 2000; Pelletier et al.
2000). Withdrawing serum or treatment with retinoic acid increases expression of Bcl-2 in
chondrocytes in vitro (Feng et al. 1998).
An immunohistochemical study revealed that expression of caspase-3 was
significantly increased in OA articular cartilage and correlated with the severity of OA
(Matsuo et al. 2001). Caspase-3 is up-regulated in chondrocyte apoptosis induced by
exogenous NO (Notoya et al. 2000; Kim et al. 2002) and selective inhibitors of caspase-3 can
inhibit chondrocyte apoptosis after treatment with NO donors (Lee et al. 2000).
This present study demonstrated that hydrostatic pressure-loaded chondrocytes
isolated from equine articular cartilages have increased NO production and have increased
Bcl-2 and caspase-3 expressions.
Materials and Methods
Equine Chondrocyte Isolation
Articular cartilage was obtained from surfaces of the distal metacarpal or metatarsal
bones from 4 young horses (2 to 4 years old). The articular cartilage was grossly normal and
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the horses had no history of joint-related disease. The horses had been submitted for either
postmortem examination or other non-joint-related studies. The cartilage was collected within
3 hours of death. The joints were aseptically disarticulated and slivers of the superficial and
deep layers of articular cartilages from the distal metacarpal or metatarsal bones were
separately harvested with a scalpel blade and placed in chilled PBS (pH 7.4) in petri dishes.
The collected cartilage slivers were finely minced into pieces 1mm or less in size and
incubated in Ham’s F12/DMEM medium (Life Technologies, Grand island, NY) containing
filter-sterilized collagenase II (final concentration of 3mg/ml; Worthington Biochemical
Corporation, Lakewood, NJ) overnight in an incubator (37C, 5% CO2, in a humidified
atmosphere). The remaining small fragments of cartilage were removed by gently and slowly
passing the cell suspension through layers of autoclaved gauzes. The filtered cell suspension
was centrifuged at 500x g for 10 minutes and the supernatant was discarded. The pelleted
cells were washed twice more with sterile saline. A small amount (20 µl) of the cell
suspension aliquot was collected and the cell numbers were determined by hemocytometer.
Cell viability was determined after staining with trypan blue. The rinsed chondrocytes were
suspended in saline containing 1.2% (v/v) alginic acid (sodium salt; Sigma, St. Louis, MO) in
a volume of 1.5 x 106 cells/ml. The cell suspension was slowly expressed through a syringe
and 22-gauge needle into a 102 mM CaCl2 solution in 6-well cell culture plates and allowed
to polymerize thereby forming uniformly-sized, 3 dimensional constructs, “beads”, which
contained the chondrocytes. After polymerization in the CaCl2 solution for 10 minutes, the
cell-laden beads were rinsed with sterile saline 3 times, Ham’s F12/DMEM twice, and
incubated in the complete Ham’s F12/DMEM medium including antibiotics and 10% fetal
bovine serum (Life Technology, Grand island, NY) until the pressure loading experiment
(within 7 days). The medium was replaced every two days.
Application of Hydrostatic Pressure
The pressure loading system consisted of two HPLC glass columns, an isocratic
HPLC pump, and a metering valve (Figure 3.1). Alginate beads embedded with either
superficial or deep layer chondrocytes were separately installed in the HPLC glass columns
(AP glass column; Waters, Milford, MA), which were connected to the isocratic HPLC pump,
and were cyclically pressurized at 1,000 ± 100 psi (approximately 6.8 ± 0.6 MPa). The
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pressure protocol consisted of repeated, 15 minute each on-off cycles for 12 hours. The peak
pressure was reached within one minute in each cycle. The complete cell culture medium in
the system was continuously recirculated throughout the experimental period. The
chondrocyte-loaded HPLC columns and the complete culture medium were placed in a cell
culture incubator at 37 °C in a humidified atmosphere with 5% CO2. The pressure was
carefully controlled and maintained with a metering valve (Hoke Fine Metering Valve;
Alltech, Deerfield, IL) at a flow rate of 1.5 ± 0.2 ml/min. The culture medium continuously
flowed at this rate in the system throughout the experimental period, even during pressure-offcycles. For the controls, cell culture dishes containing superficial and deep layer
chondrocytes in alginate beads were placed next to the glass columns in the incubator. After
pressure treatment, the alginate beads were collected from the HPLC columns, placed in 2ml
of complete medium, and incubated for 36 hours at 37 °C in a humidified atmosphere with
5% CO2.
Nitrite Assay
A colorimetric assay, using Greiss reagents and sodium nitrite (NaNO2) as the
standard, was used to measure nitrite (NO2) in the cell culture medium (2ml per each group)
that was collected after the 36-hour-incubation following the pressure loading. In brief, 100
µl of each standard solution or sample medium was added to a 96-well cell culture plate on
ice, mixed with 50 µl of freshly prepared sulfanilamide (10mg/ml in 5 % orthophosphoric
acid; Sigma, St. Louis, MO), and incubated for 10 minutes under dimmed lights. The plate
was removed from the ice and incubated for 30 minutes after adding 50 µl of NED [N-(1naphtyl)ethylenediamine HCl; Sigma, St. Louis, MO] (1mg/ml in water) to each well.
Absorbance at 550 nm wavelength was determined by a spectrophotometric plate reader. A
nitrite standard graph and estimated concentrations of nitrite in the samples were statistically
calculated by linear regression.
Immunocytochemistry for Bcl-2 and Caspase-3
The chondrocytes were isolated from the alginate beads by dissolution with EDTA
(final concentration of 25 mM for 10 minutes) and washed twice with saline. The numbers of
isolated chondrocytes in each group were counted with a hemocytometer. Approximately 5 x
104 cells from each group were adhered to a glass slide by cytospin, fixed in chilled 1%
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paraformaldehyde for 10 minutes, air-dried, and stored at –70 °C for later use. For
immunocytochemistry, the avidin-biotin-peroxidase complex method was used (Vectrastain
ABC kit, Vector Laboratories, Burlingame, CA). Chondrocytes on the slides were pretreated
with 3% hydrogen peroxide for 5 minutes and 0.5% Triton X-100 solution for 5 minutes.
Rabbit anti-human Bcl-2 polyclonal antisera and goat anti-human caspase-3 p20 subunit
polyclonal antisera were used as primary antibodies (Santa Cruz Biotechnology).
Diaminobenzidine tetrahydrochloride (DAB; Sigma, St. Louis, MO) was the chromogen for
detection. For counter-staining, 0.5% Methyl green in 0.1M sodium acetate was applied for
10 min.
Data Analysis
The SAS statistical package (GLM procedure) was used to analyze the data. The data
of nitrite concentrations from each group were normalized by log transformation. The logtransformed data were analyzed by analysis of variance in a Randomized Block Design with
horse as the blocking factor and pressure-loading treatment, cartilage layer, and treatment and
cartilage layer interactions as effects in the model. Pairwise comparisons were conducted
with the LSMEANS option to obtain t-tests. All comparisons were considered significant at
p≤ 0.05.
Results
Nitrite Assay
Nitrite in each 2 ml cell culture medium was calculated in micromolar concentration
per 103 cells (Table 4.1). The pressure-loaded chondrocytes from the superficial layers of
articular cartilages produced significantly higher concentrations of nitrite than the control
group (p=0.002). The pressure-loaded deep layer chondrocytes also produced more nitrite
than the control, although statistically not significant (p=0.07).
Immunocytochemistry for Bcl-2
Most superficial and deep layer chondrocytes from both control and pressure-loaded
groups showed positive immunoreactivity for Bcl-2. But, pressure-loaded chondrocytes from
both superficial and deep layers were more intensely stained with polyclonal Bcl-2 antibody
(Figures 4.1 – 4.4). Positively stained pressure-loaded cells contained mostly fine, but only
occaionally coarse, brown chromogen granules diffusely and uniformly scattered throughout
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the cytoplasm. In contrast, control chondrocytes often had variably distributed, fine
chromogen granules in the cytoplasm. In the control groups, deep layer chondrocytes
exhibited stronger staining than chondrocytes from superficial layers.

Table 4.1. Nitrite concentration from pressure-loaded and control chondrocytes from equine
articular cartilages (µM/103 cells)
Horse

PS a

CS

PD b

CD

1

11.99

2.02

18.03

5.52

2

26.53

15.80

22.96

20.28

3

28.23

10.43

28.70

20.50

4

64.67

26.14

88.80

66.51

PS: Pressure-loaded chondrocytes from superficial layer
CS: Control chondrocytes from superficial layer
PD: Pressure-loaded chondrocytes from deep layer
CD: Control chondrocytes from deep layer
a
b

: PS vs. CS, p = 0.002
: PD vs. CD, p = 0.07
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Figure 4.1. Immunocytochemistry for Bcl-2 in the control chondrocytes isolated from
superficial layers of equine articular cartilages. The cytoplasm is partially stained with fine
chromogen particles.

Figure 4.2. Immunocytochemistry for Bcl-2 in the hydrostatic pressure-loaded chondrocytes
isolated from superficial layers of equine articular cartilages. Note the stronger
immunopositivity compared with the control.
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Figure 4.3. Immunocytochemistry for Bcl-2 in the control chondrocytes isolated from deep
layers of equine articular cartilages. The cytoplasm is partially stained with fine chromogen
granules while immunopositivity appears stronger than the control chondrocytes from
superficial layers.

Figure 4.4. Immunocytochemistry for Bcl-2 in the hydrostatic pressure-loaded chondrocytes
isolated from deep layers of equine articular cartilages. The cytoplasm is diffusely and
strongly stained.

49

Immunocytochemistry for Caspase-3
The primary antibody used for this study was goat polyclonal antisera against human
caspase-3 p20 subunits, which detect both pre-activated and activated forms of caspase-3.
Pressure-loaded chondrocytes from both superficial and deep layers demonstrated higher
immunoreactivity than the corresponding control groups (Figures 4.5 – 4.8). Two distinct
patterns of immunocytochemical staining were noted between cytoplasm and nuclei. The
cytoplasm contained partially to diffusely scattered fine chromogen granules, but the nuclei
were discretely and densely stained. The pressure-loaded chondrocytes had more intense
granular staining with chromogen granules in the cytoplasm and more frequently stained
nuclei.

Figure 4.5. Immunocytochemistry for caspase-3 in the control chondrocytes isolated from
superficial layers of equine articular cartilages. Note diffusely stained cytoplasm and
occasional densely stained nuclei.
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Figure 4.6. Immunocytochemistry for caspase-3 in the hydrostatic pressure-loaded
chondrocytes isolated from superficial layers of equine articular cartilages. The densely
stained nuclei are more frequent and the cytoplasm shows increased immunopositivity over
the control.

Figure 4.7. Immunocytochemistry for caspase-3 in the control chondrocytes isolated from
deep layers of equine articular cartilages. Note diffusely stained cytoplasm and occasional
densely stained nuclei.
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Figure 4.8. Immunocytochemistry for caspase-3 in the hydrostatic pressure-loaded
chondrocytes isolated from deep layers of equine articular cartilages. Note frequently stained
nuclei as well as much stronger immunopositivity in the cytoplasm compared with the
control.
Discussion
The pressure-loaded equine articular chondrocytes produced increased NO production
and had increased expression of Bcl-2 and caspase-3 compared with the control groups.
These results were consistent with previous experimental results (chapter II) of chondrocyte
apoptosis, which demonstrated that hydrostatic cyclic pressure induced increased chondrocyte
apoptosis.
NO is a short-lived endogenous mediator with ambivalent actions; physiologic and
pathologic (Liaudet et al. 2000). Excessive production of NO has been linked to cartilage
catabolism (Hauselmann et al. 1998; Pelletier et al. 1998; Spreng et al. 2000) and chondrocyte
apoptosis (Hashimoto et al. 1998c; Blanco et al. 1998; Hashimoto et al. 1999). The present
study demonstrated that pressure-loaded equine articular chondrocytes produced higher
concentrations of NO, in the form of nitrite, suggesting that mechanical pressure can be a
direct cause of NO production in articular chondrocytes. The increased production of NO
correlated with an increased percentage of apoptosis found in the pressure-loaded
chondrocytes. Collectively, these observations suggest that increased NO may be responsible
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for chondrocyte apoptosis induced by cyclic hydrostatic pressure. Recent studies have
suggested that peroxynitrite, a potential pathologic byproduct of NO, may be the direct
mediator for the NO-dependent apoptosis by ways of DNA injury, cell cycle arrest,
mitochondrial damage, and activation of caspase-3 (Liaudet et al. 2000; Lee et al. 2000;
Yabuki et al. 2000; Teixeira et al. 2001; Kim et al. 2002). NO and peroxynitrite can cause
direct permeabilization of proteoliposomes containing adenine nucleotide translocator, one of
the key components of the permeability transition pore complex in the mitrochondrial
membranes, resulting in release of cytochrome c into the cytoplasm and the consequential
apoptosis (Vieira et al. 2001). Released cytochrome c activates caspase-9 by binding to the
caspase-activating protein Apaf-1 (apoptotic protease activating factor-1). Subsequent
activation of caspase-3, a potent execution caspase, occurs by activated caspase-9 (Saikumar
et al. 1999). Conversely, NO also has been reported to have anti-apoptotic activity by
delaying the apoptotic process (Leist et al. 1999).
Cell demise occurs mainly via two distinct pathways; apoptosis and necrosis.
Chondrocyte necrosis has been identified in the mechanically damaged articular cartilages as
well (Loening et al. 2000; Chen et al. 2001). Direct cellular trauma such as membrane rupture
is a potential cause of the chondrocyte necrosis. A unique characteristic of apoptosis is the
high-energy demand to execute the process (Eguchi et al. 1997). ATP depletion during
apoptosis leads to failure of sequential activation of execution caspases, which are required
for the characteristic morphology of apoptosis (Nicotera and Leist 1997). In those
circumstances, the cells still die by switching the pathway of death from apoptosis to necrosis.
NO has been implicated to inhibit mitochondrial ATP generation and switch apoptosis to
necrosis (Leist et al. 1999). Therefore, when NO-dependent chondrocyte death occurs, not
only apoptosis but also necrosis and secondary necrosis (overlapping processes) can be
expected (Saikumar et al. 1999). Based on this idea, some of the cells that are stained
positively with TUNEL method but have the morphology of necrosis (ruptured cell
membrane) may not be falsely positive for apoptosis but may be secondary necrosis that
began as apoptosis but completed as necrosis due to energy depletion by NO.
Bcl-2 is one of the anti-apoptotic proteins among the Bcl-2 family proteins. Antiapoptotic members include Bcl-2, Bcl-XL, Bcl-w, etc. and pro-apoptotic members are Bax,
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Bak, Bid, Bim, Bad, etc. (Reed 2000). Bcl-2 has a hydrophobic domain of amino acids near
its carboxy-terminus that anchors it in the outer mitochondrial membrane. Thus, it forms a
heterodimer with another Bcl-2 family protein to assemble a permeability transition pore
complex. In contrast, some other Bcl-2 family proteins like pro-apoptotic proteins Bid, Bim,
and Bad lack the transmembrane domains to locate in the cytosol but still can translocate into
mitochondria and form heterodimers with other Bcl-2 family proteins in the mitochondrial
outer membrane. Pro-apoptotic Bcl-2 family proteins like Bax can release cytochrome c by
forming pores in the mitochondrial membrane (Reed 2000; Geske et al. 2001). It is believed
that the ratio of pro-apoptotic to anti-apoptotic Bcl-2 family proteins is important in
determining cell fate (Adams and Cory 1998). In articular cartilages, Bcl-2 expression is
increased in normal young human cartilages (Kim et al. 2000) and, interestingly, OA
cartilages also show markedly elevated Bcl-2 expression (Kim et al. 2000; Pelletier et al.
2000). In conjunction with the results from our previous experiment, high pressure-loaded
chondrocytes also showed increased cell apoptosis and concurrently elevated Bcl-2
expression. This finding of increased cell apoptosis with increased Bcl-2 expression might be
a paradox because it is expected that high Bcl-2 would inhibit cell apoptosis. The pressureloaded chondrocytes may attempt compensate for the adverse high-pressure condition with
the up-regulation of Bcl-2 expression to escape apoptosis. Of the control groups, the
chondrocytes from deep layers have higher expression of Bcl-2 than those from superficial
layers. This result could be explained with the same reasoning, i.e. more mechanical damage
during the sample preparation. In the previous experiment, chondrocytes from the deep layers
exhibited increased apoptosis.
Caspase-3 is one of the most important execution caspases for completion of the
apoptosis process after its activation by activated caspase-9 (Saikumar et al. 1999; Afford and
Randhawa 2000; Reed 2000). Cytochrome c released from the mitochondria binds to Apaf-1
(apoptotic protease activating factor-1) and this complex activates procaspase-9. Increased
expression of caspase-3 was confirmed in human OA articular cartilages and surgically
induced canine OA models. This expression was correlated with chondrocyte apoptosis and
OA lesions (Pelletier et al. 2000; Matsuo et al. 2001). NO-induced apoptotic chondrocytes
up-regulate caspase-3 (Notoya et al. 2000; Kim et al. 2002). In a dose-dependant manner,
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selective inhibitors of caspase-3 decrease caspase-3 expression as well as decreasing
chondrocyte apoptosis (Lee et al. 2000; Pelletier et al. 2000). This present in vitro study
reconfirms that increased amounts of endogenous NO, induced by high-pressure load, are
correlated with high caspase-3 expression in the articular chondrocytes.
In summary, we have shown that cyclic hydrostatic pressure can induce equine
articular chondrocyte apoptosis with increased NO production and increased Bcl-2 and
caspase-3 expressions. This in vitro experiment demonstrated that mechanical stress could
be a major cause of chondrocyte apoptosis. Pressure-induced NO production may play a
critical role in the chondrocyte apoptotic process through Bcl-2 and caspase-3 mediated
mechanisms.
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SUMMARY
We studied the roles of chondrocyte apoptosis and hydrostatic pressure in the
pathogenesis of equine osteoarthritis. Chondrocyte apoptosis occurred much more frequently
in equine OA cartilages than normal cartilages of horses. Within the same OA cartilage, more
apoptotic chondrocytes were found in the lesional area than in the non-lesional area.
Chondrocyte apoptosis and degradation of equine articular cartilage were closely correlated.
A high incidence of chondrocyte apoptosis was noted in the severely degraded cartilage
matrix. These findings seemed to corroborate earlier observations in human and experimental
OA (Blanco et al. 1998; Hashimoto et al. 1998a; Hashimoto et al. 1998c; Pelletier et al. 1998;
Kim et al. 2000). In addition, the observation of frequent chondrocyte apoptosis at the
margins of the may indicate that chondrocyte apoptosis precedes and may cause matrix
degeneration. This is further supported by increased apoptosis in the non-leisonal areas
compared with normal cartilage. Immunohistochemical studies revealed concurrently
increased endogenous NO production by chondrocytes and matrix degradation. The
topographic distribution of chondrocyte apoptosis, matrix degradation, and endogenous NO
completely overlapped in equine OA cartilage, suggesting each pathological change is closely
related to the others in the pathogenesis of equine OA.
Mechanical stress is believed to be a major factor of OA and hydrostatic pressure is a
major physical force that is generated in articular joints (Ateshian et al. 1994; Mow et al.
1999). Cyclic hydrostatic pressure (approximately 6.8 ± 0.6 MPa) for 12 hours in a novel
pressure-loading system induced a high percentage of apoptosis of equine chondrocytes
compared with non-loaded, control chondrocytes. This observation suggests that mechanical
stress may directly induce chondrocyte apoptosis. The finding of mechanically-induced
chondrocyte apoptosis without any apoptosis-related factor from the extracellular matrix
supports the hypothesis that chondrocyte apoptosis may be an early change of OA and may
precede matrix degradation. We demonstrated that a relative increase of apoptotic
chondrocytes after the pressure loading was observed more in the superficial chondrocytes,
compared with the chondrocytes from deep layers. This result agrees with the findings in
other in vivo studies (Blanco et al. 1998; Hashimoto et al. 1998c).
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The pressure-loaded equine articular chondrocytes produced increased NO compared
with the control group. This observation is consistent with the frequent incidence of
chondrocyte apoptosis in the in vitro pressure-loading experiments as well as in the in vivo
equine OA cartilages. The pressure-loaded chondrocytes showed elevated Bcl-2 and caspase3 expressions. Increased cell apoptosis in the presence of increased Bcl-2 expression is
paradoxical because Bcl-2 is an inhibitor of cell apoptosis. It is conceivable that the
chondrocytes may try to compensate for the adverse high-pressure condition by the upregulation of Bcl-2 expression in an attempt to escape apoptosis. Increased caspase-3
expression in the pressure-loaded chondrocytes in this study confirmed that endogenous NO
production and caspase-3 expression are concurrently increased in the articular chondrocytes.
Collectively, we have shown that hydrostatic pressure induces chondrocyte apoptosis
that is associated with increased production of endogenous NO and elevates expressions of
Bcl-2 and caspase-3. This in vitro experiment demonstrates that mechanical stress could be a
major cause of chondrocyte apoptosis without prior extracellular matrix changes because
matrix was absent from this system. Pressure-induced NO has a critical role in the
chondrocyte apoptosis process through caspase-3 mediated mechanisms in spite of Bcl-2 upregulation. Because mechanical stress, i.e. trauma, is believed to be the major cause of equine
OA, the data generated herein supports endogenous NO-induced chondrocyte apoptosis as a
potential mechanism for the pathogenesis of OA. Furthermore, Bcl-2 and caspase-3 are
supported as regulatory or mediating factors in this process.
Our pressure-loading system successfully provided an experimental high-pressure
condition, which is similar to that in the articular joints. It is an advantageous in vitro system,
which is easy to control and manipulate experimentally. Our system may be used to examine
specific biological actions and interactions of chondrocytes under high pressure and may be
useful to elaborate and elucidate mechanisms of chondrocyte apoptosis.
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